#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Language Context Processing Deficits in Schizophrenia: The Role of Attentional Engagement Individuals with schizophrenia exhibit problems in language comprehension that are most evident during discourse processing.
1-1	0-8	Language	_
1-2	9-16	Context	_
1-3	17-27	Processing	_
1-4	28-36	Deficits	_
1-5	37-39	in	_
1-6	40-53	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-7	54-55	:	_
1-8	56-59	The	_
1-9	60-64	Role	_
1-10	65-67	of	_
1-11	68-79	Attentional	_
1-12	80-90	Engagement	_
1-13	91-102	Individuals	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-14	103-107	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-15	108-121	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-16	122-129	exhibit	_
1-17	130-138	problems	_
1-18	139-141	in	_
1-19	142-150	language	_
1-20	151-164	comprehension	_
1-21	165-169	that	_
1-22	170-173	are	_
1-23	174-178	most	_
1-24	179-186	evident	_
1-25	187-193	during	_
1-26	194-203	discourse	_
1-27	204-214	processing	_
1-28	215-216	.	_

Text=We hypothesized that deficits in cognitive control contribute to these comprehension deficits during discourse processing, and investigated the underlying cognitive-neural mechanisms using EEG (alpha power) and ERPs (N400).
2-1	217-219	We	_
2-2	220-232	hypothesized	_
2-3	233-237	that	_
2-4	238-246	deficits	_
2-5	247-249	in	_
2-6	250-259	cognitive	_
2-7	260-267	control	_
2-8	268-278	contribute	_
2-9	279-281	to	_
2-10	282-287	these	_
2-11	288-301	comprehension	_
2-12	302-310	deficits	_
2-13	311-317	during	_
2-14	318-327	discourse	_
2-15	328-338	processing	_
2-16	339-340	,	_
2-17	341-344	and	_
2-18	345-357	investigated	_
2-19	358-361	the	_
2-20	362-372	underlying	_
2-21	373-389	cognitive-neural	_
2-22	390-400	mechanisms	_
2-23	401-406	using	_
2-24	407-410	EEG	_
2-25	411-412	(	_
2-26	413-418	alpha	_
2-27	419-424	power	_
2-28	425-426	)	_
2-29	427-430	and	_
2-30	431-435	ERPs	_
2-31	436-437	(	_
2-32	438-442	N400	_
2-33	443-444	)	_
2-34	445-446	.	_

Text=N400 amplitudes to globally supported or unsupported target words near the end of stories were used to index sensitivity to previous context.
3-1	447-451	N400	_
3-2	452-462	amplitudes	_
3-3	463-465	to	_
3-4	466-474	globally	_
3-5	475-484	supported	_
3-6	485-487	or	_
3-7	488-499	unsupported	_
3-8	500-506	target	_
3-9	507-512	words	_
3-10	513-517	near	_
3-11	518-521	the	_
3-12	522-525	end	_
3-13	526-528	of	_
3-14	529-536	stories	_
3-15	537-541	were	_
3-16	542-546	used	_
3-17	547-549	to	_
3-18	550-555	index	_
3-19	556-567	sensitivity	_
3-20	568-570	to	_
3-21	571-579	previous	_
3-22	580-587	context	_
3-23	588-589	.	_

Text=ERPs showed reduced sensitivity to context in patients versus controls.
4-1	590-594	ERPs	_
4-2	595-601	showed	_
4-3	602-609	reduced	_
4-4	610-621	sensitivity	_
4-5	622-624	to	_
4-6	625-632	context	_
4-7	633-635	in	_
4-8	636-644	patients	_
4-9	645-651	versus	_
4-10	652-660	controls	_
4-11	661-662	.	_

Text=EEG alpha-band activity was used to index attentional engagement while participants listened to the stories.
5-1	663-666	EEG	_
5-2	667-677	alpha-band	_
5-3	678-686	activity	_
5-4	687-690	was	_
5-5	691-695	used	_
5-6	696-698	to	_
5-7	699-704	index	_
5-8	705-716	attentional	_
5-9	717-727	engagement	_
5-10	728-733	while	_
5-11	734-746	participants	_
5-12	747-755	listened	_
5-13	756-758	to	_
5-14	759-762	the	_
5-15	763-770	stories	_
5-16	771-772	.	_

Text=We found that context effects varied with attentional engagement in both groups, as well as with negative symptom severity in patients.
6-1	773-775	We	_
6-2	776-781	found	_
6-3	782-786	that	_
6-4	787-794	context	_
6-5	795-802	effects	_
6-6	803-809	varied	_
6-7	810-814	with	_
6-8	815-826	attentional	_
6-9	827-837	engagement	_
6-10	838-840	in	_
6-11	841-845	both	_
6-12	846-852	groups	_
6-13	853-854	,	_
6-14	855-857	as	_
6-15	858-862	well	_
6-16	863-865	as	_
6-17	866-870	with	_
6-18	871-879	negative	_
6-19	880-887	symptom	_
6-20	888-896	severity	_
6-21	897-899	in	_
6-22	900-908	patients	_
6-23	909-910	.	_

Text=Both groups demonstrated trial-to-trial fluctuations in alpha.
7-1	911-915	Both	_
7-2	916-922	groups	_
7-3	923-935	demonstrated	_
7-4	936-950	trial-to-trial	_
7-5	951-963	fluctuations	_
7-6	964-966	in	_
7-7	967-972	alpha	_
7-8	973-974	.	_

Text=Relatively high alpha power was associated with compromised discourse processing in participants with schizophrenia when it occurred during any early portion of the story.
8-1	975-985	Relatively	_
8-2	986-990	high	_
8-3	991-996	alpha	_
8-4	997-1002	power	_
8-5	1003-1006	was	_
8-6	1007-1017	associated	_
8-7	1018-1022	with	_
8-8	1023-1034	compromised	_
8-9	1035-1044	discourse	_
8-10	1045-1055	processing	_
8-11	1056-1058	in	_
8-12	1059-1071	participants	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-13	1072-1076	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-14	1077-1090	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-15	1091-1095	when	_
8-16	1096-1098	it	_
8-17	1099-1107	occurred	_
8-18	1108-1114	during	_
8-19	1115-1118	any	_
8-20	1119-1124	early	_
8-21	1125-1132	portion	_
8-22	1133-1135	of	_
8-23	1136-1139	the	_
8-24	1140-1145	story	_
8-25	1146-1147	.	_

Text=In contrast, discourse processing was only compromised in controls only when alpha was relatively high for longer segments of the stories.
9-1	1148-1150	In	_
9-2	1151-1159	contrast	_
9-3	1160-1161	,	_
9-4	1162-1171	discourse	_
9-5	1172-1182	processing	_
9-6	1183-1186	was	_
9-7	1187-1191	only	_
9-8	1192-1203	compromised	_
9-9	1204-1206	in	_
9-10	1207-1215	controls	_
9-11	1216-1220	only	_
9-12	1221-1225	when	_
9-13	1226-1231	alpha	_
9-14	1232-1235	was	_
9-15	1236-1246	relatively	_
9-16	1247-1251	high	_
9-17	1252-1255	for	_
9-18	1256-1262	longer	_
9-19	1263-1271	segments	_
9-20	1272-1274	of	_
9-21	1275-1278	the	_
9-22	1279-1286	stories	_
9-23	1287-1288	.	_

Text=Our results indicate that shifts in attention from the story context may be more detrimental to discourse processing for participants with schizophrenia than for controls, most likely due to an impaired ability to benefit from global context.
10-1	1289-1292	Our	_
10-2	1293-1300	results	_
10-3	1301-1309	indicate	_
10-4	1310-1314	that	_
10-5	1315-1321	shifts	_
10-6	1322-1324	in	_
10-7	1325-1334	attention	_
10-8	1335-1339	from	_
10-9	1340-1343	the	_
10-10	1344-1349	story	_
10-11	1350-1357	context	_
10-12	1358-1361	may	_
10-13	1362-1364	be	_
10-14	1365-1369	more	_
10-15	1370-1381	detrimental	_
10-16	1382-1384	to	_
10-17	1385-1394	discourse	_
10-18	1395-1405	processing	_
10-19	1406-1409	for	_
10-20	1410-1422	participants	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-21	1423-1427	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-22	1428-1441	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-23	1442-1446	than	_
10-24	1447-1450	for	_
10-25	1451-1459	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
10-26	1460-1461	,	_
10-27	1462-1466	most	_
10-28	1467-1473	likely	_
10-29	1474-1477	due	_
10-30	1478-1480	to	_
10-31	1481-1483	an	_
10-32	1484-1492	impaired	_
10-33	1493-1500	ability	_
10-34	1501-1503	to	_
10-35	1504-1511	benefit	_
10-36	1512-1516	from	_
10-37	1517-1523	global	_
10-38	1524-1531	context	_
10-39	1532-1533	.	_

Text=Methods Participants Thirty individuals with schizophrenia or a schizophrenia-spectrum disorder and 27 healthy controls completed the study.
11-1	1534-1541	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
11-2	1542-1554	Participants	_
11-3	1555-1561	Thirty	_
11-4	1562-1573	individuals	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-5	1574-1578	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-6	1579-1592	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-7	1593-1595	or	_
11-8	1596-1597	a	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
11-9	1598-1620	schizophrenia-spectrum	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
11-10	1621-1629	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
11-11	1630-1633	and	_
11-12	1634-1636	27	_
11-13	1637-1644	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-14	1645-1653	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
11-15	1654-1663	completed	_
11-16	1664-1667	the	_
11-17	1668-1673	study	_
11-18	1674-1675	.	_

Text=All participants provided informed consent prior to enrollment, with the approval of the Institutional Review Board at the University of California, Davis.
12-1	1676-1679	All	_
12-2	1680-1692	participants	_
12-3	1693-1701	provided	_
12-4	1702-1710	informed	_
12-5	1711-1718	consent	_
12-6	1719-1724	prior	_
12-7	1725-1727	to	_
12-8	1728-1738	enrollment	_
12-9	1739-1740	,	_
12-10	1741-1745	with	_
12-11	1746-1749	the	_
12-12	1750-1758	approval	_
12-13	1759-1761	of	_
12-14	1762-1765	the	_
12-15	1766-1779	Institutional	_
12-16	1780-1786	Review	_
12-17	1787-1792	Board	_
12-18	1793-1795	at	_
12-19	1796-1799	the	_
12-20	1800-1810	University	_
12-21	1811-1813	of	_
12-22	1814-1824	California	_
12-23	1825-1826	,	_
12-24	1827-1832	Davis	_
12-25	1833-1834	.	_

Text=All participants were compensated at a rate of $15 per hour for EEG and behavioral testing; patient participants were compensated $25 for completion of a clinical interview and symptom ratings session.
13-1	1835-1838	All	_
13-2	1839-1851	participants	_
13-3	1852-1856	were	_
13-4	1857-1868	compensated	_
13-5	1869-1871	at	_
13-6	1872-1873	a	_
13-7	1874-1878	rate	_
13-8	1879-1881	of	_
13-9	1882-1883	$	_
13-10	1884-1886	15	_
13-11	1887-1890	per	_
13-12	1891-1895	hour	_
13-13	1896-1899	for	_
13-14	1900-1903	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
13-15	1904-1907	and	_
13-16	1908-1918	behavioral	_
13-17	1919-1926	testing	_
13-18	1927-1928	;	_
13-19	1929-1936	patient	_
13-20	1937-1949	participants	_
13-21	1950-1954	were	_
13-22	1955-1966	compensated	_
13-23	1967-1968	$	_
13-24	1969-1971	25	_
13-25	1972-1975	for	_
13-26	1976-1986	completion	_
13-27	1987-1989	of	_
13-28	1990-1991	a	_
13-29	1992-2000	clinical	_
13-30	2001-2010	interview	_
13-31	2011-2014	and	_
13-32	2015-2022	symptom	_
13-33	2023-2030	ratings	_
13-34	2031-2038	session	_
13-35	2039-2040	.	_

Text=Participants with schizophrenia were within 5 years of the onset of their psychotic symptoms, and were recruited through the Early Diagnosis and Preventive Treatment of Psychosis (EDAPT) clinic at the University of California, Davis Medical Center.
14-1	2041-2053	Participants	_
14-2	2054-2058	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-3	2059-2072	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-4	2073-2077	were	_
14-5	2078-2084	within	_
14-6	2085-2086	5	_
14-7	2087-2092	years	_
14-8	2093-2095	of	_
14-9	2096-2099	the	_
14-10	2100-2105	onset	_
14-11	2106-2108	of	_
14-12	2109-2114	their	_
14-13	2115-2124	psychotic	_
14-14	2125-2133	symptoms	_
14-15	2134-2135	,	_
14-16	2136-2139	and	_
14-17	2140-2144	were	_
14-18	2145-2154	recruited	_
14-19	2155-2162	through	_
14-20	2163-2166	the	_
14-21	2167-2172	Early	_
14-22	2173-2182	Diagnosis	_
14-23	2183-2186	and	_
14-24	2187-2197	Preventive	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-25	2198-2207	Treatment	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-26	2208-2210	of	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-27	2211-2220	Psychosis	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-28	2221-2222	(	_
14-29	2223-2228	EDAPT	_
14-30	2229-2230	)	_
14-31	2231-2237	clinic	_
14-32	2238-2240	at	_
14-33	2241-2244	the	_
14-34	2245-2255	University	_
14-35	2256-2258	of	_
14-36	2259-2269	California	_
14-37	2270-2271	,	_
14-38	2272-2277	Davis	_
14-39	2278-2285	Medical	_
14-40	2286-2292	Center	_
14-41	2293-2294	.	_

Text=Four participants in the schizophrenia (SZ) group and three HC were ultimately excluded from all analyses due to the presence of excessive artifacts in their EEG data (see EEG Recording & Processing section below for details).
15-1	2295-2299	Four	_
15-2	2300-2312	participants	_
15-3	2313-2315	in	_
15-4	2316-2319	the	_
15-5	2320-2333	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-6	2334-2335	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-7	2336-2338	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-8	2339-2340	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-9	2341-2346	group	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-10	2347-2350	and	_
15-11	2351-2356	three	_
15-12	2357-2359	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
15-13	2360-2364	were	_
15-14	2365-2375	ultimately	_
15-15	2376-2384	excluded	_
15-16	2385-2389	from	_
15-17	2390-2393	all	_
15-18	2394-2402	analyses	_
15-19	2403-2406	due	_
15-20	2407-2409	to	_
15-21	2410-2413	the	_
15-22	2414-2422	presence	_
15-23	2423-2425	of	_
15-24	2426-2435	excessive	_
15-25	2436-2445	artifacts	_
15-26	2446-2448	in	_
15-27	2449-2454	their	_
15-28	2455-2458	EEG	_
15-29	2459-2463	data	_
15-30	2464-2465	(	_
15-31	2466-2469	see	_
15-32	2470-2473	EEG	_
15-33	2474-2483	Recording	_
15-34	2484-2485	&	_
15-35	2486-2496	Processing	_
15-36	2497-2504	section	_
15-37	2505-2510	below	_
15-38	2511-2514	for	_
15-39	2515-2522	details	_
15-40	2523-2524	)	_
15-41	2525-2526	.	_

Text=Thus, the SZ group included 26 individuals and the HC group included 23 individuals.
16-1	2527-2531	Thus	_
16-2	2532-2533	,	_
16-3	2534-2537	the	_
16-4	2538-2540	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
16-5	2541-2546	group	_
16-6	2547-2555	included	_
16-7	2556-2558	26	_
16-8	2559-2570	individuals	_
16-9	2571-2574	and	_
16-10	2575-2578	the	_
16-11	2579-2581	HC	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
16-12	2582-2587	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
16-13	2588-2596	included	_
16-14	2597-2599	23	_
16-15	2600-2611	individuals	_
16-16	2612-2613	.	_

Text=Participants with schizophrenia ranged in age from 18–30 years (mean: 22.6); 81% were male.
17-1	2614-2626	Participants	_
17-2	2627-2631	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
17-3	2632-2645	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
17-4	2646-2652	ranged	_
17-5	2653-2655	in	_
17-6	2656-2659	age	_
17-7	2660-2664	from	_
17-8	2665-2670	18–30	_
17-9	2671-2676	years	_
17-10	2677-2678	(	_
17-11	2679-2683	mean	_
17-12	2684-2685	:	_
17-13	2686-2690	22.6	_
17-14	2691-2692	)	_
17-15	2693-2694	;	_
17-16	2695-2697	81	_
17-17	2698-2699	%	_
17-18	2700-2704	were	_
17-19	2705-2709	male	_
17-20	2710-2711	.	_

Text=HC ranged in age from 18–29 years (mean: 22); 74% were male.
18-1	2712-2714	HC	_
18-2	2715-2721	ranged	_
18-3	2722-2724	in	_
18-4	2725-2728	age	_
18-5	2729-2733	from	_
18-6	2734-2739	18–29	_
18-7	2740-2745	years	_
18-8	2746-2747	(	_
18-9	2748-2752	mean	_
18-10	2753-2754	:	_
18-11	2755-2757	22	_
18-12	2758-2759	)	_
18-13	2760-2761	;	_
18-14	2762-2764	74	_
18-15	2765-2766	%	_
18-16	2767-2771	were	_
18-17	2772-2776	male	_
18-18	2777-2778	.	_

Text=All participants were recruited with the following exclusion criteria: (1) IQ below 70, as measured by the Wechsler Abbreviated Scale of Intelligence or Wechsler Test of Adult Reading; (2) history of neurological illness, including head injury; (3) substance-related disorder in the previous six months; (4) uncontrolled medical illness; (5) history of electro-convulsive therapy.
19-1	2779-2782	All	_
19-2	2783-2795	participants	_
19-3	2796-2800	were	_
19-4	2801-2810	recruited	_
19-5	2811-2815	with	_
19-6	2816-2819	the	_
19-7	2820-2829	following	_
19-8	2830-2839	exclusion	_
19-9	2840-2848	criteria	_
19-10	2849-2850	:	_
19-11	2851-2852	(	_
19-12	2853-2854	1	_
19-13	2855-2856	)	_
19-14	2857-2859	IQ	_
19-15	2860-2865	below	_
19-16	2866-2868	70	_
19-17	2869-2870	,	_
19-18	2871-2873	as	_
19-19	2874-2882	measured	_
19-20	2883-2885	by	_
19-21	2886-2889	the	_
19-22	2890-2898	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
19-23	2899-2910	Abbreviated	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
19-24	2911-2916	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
19-25	2917-2919	of	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
19-26	2920-2932	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
19-27	2933-2935	or	_
19-28	2936-2944	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
19-29	2945-2949	Test	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
19-30	2950-2952	of	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
19-31	2953-2958	Adult	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
19-32	2959-2966	Reading	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
19-33	2967-2968	;	_
19-34	2969-2970	(	_
19-35	2971-2972	2	_
19-36	2973-2974	)	_
19-37	2975-2982	history	_
19-38	2983-2985	of	_
19-39	2986-2998	neurological	_
19-40	2999-3006	illness	_
19-41	3007-3008	,	_
19-42	3009-3018	including	_
19-43	3019-3023	head	_
19-44	3024-3030	injury	_
19-45	3031-3032	;	_
19-46	3033-3034	(	_
19-47	3035-3036	3	_
19-48	3037-3038	)	_
19-49	3039-3056	substance-related	_
19-50	3057-3065	disorder	_
19-51	3066-3068	in	_
19-52	3069-3072	the	_
19-53	3073-3081	previous	_
19-54	3082-3085	six	_
19-55	3086-3092	months	_
19-56	3093-3094	;	_
19-57	3095-3096	(	_
19-58	3097-3098	4	_
19-59	3099-3100	)	_
19-60	3101-3113	uncontrolled	_
19-61	3114-3121	medical	_
19-62	3122-3129	illness	_
19-63	3130-3131	;	_
19-64	3132-3133	(	_
19-65	3134-3135	5	_
19-66	3136-3137	)	_
19-67	3138-3145	history	_
19-68	3146-3148	of	_
19-69	3149-3167	electro-convulsive	_
19-70	3168-3175	therapy	_
19-71	3176-3177	.	_

Text=Twenty-four of the 26 participants with schizophrenia were right-handed (92.3%), and 21 of the 23 HC were right-handed (91.3%).
20-1	3178-3189	Twenty-four	_
20-2	3190-3192	of	_
20-3	3193-3196	the	_
20-4	3197-3199	26	_
20-5	3200-3212	participants	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-6	3213-3217	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-7	3218-3231	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-8	3232-3236	were	_
20-9	3237-3249	right-handed	_
20-10	3250-3251	(	_
20-11	3252-3256	92.3	_
20-12	3257-3258	%	_
20-13	3259-3260	)	_
20-14	3261-3262	,	_
20-15	3263-3266	and	_
20-16	3267-3269	21	_
20-17	3270-3272	of	_
20-18	3273-3276	the	_
20-19	3277-3279	23	_
20-20	3280-3282	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-21	3283-3287	were	_
20-22	3288-3300	right-handed	_
20-23	3301-3302	(	_
20-24	3303-3307	91.3	_
20-25	3308-3309	%	_
20-26	3310-3311	)	_
20-27	3312-3313	.	_

Text=HC were evaluated using the Structured Clinical Interview for DSM-IV-TR (SCID) to exclude those with a history of an Axis 1 disorder or first-degree relatives with a psychotic disorder.
21-1	3314-3316	HC	_
21-2	3317-3321	were	_
21-3	3322-3331	evaluated	_
21-4	3332-3337	using	_
21-5	3338-3341	the	_
21-6	3342-3352	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-7	3353-3361	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-8	3362-3371	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-9	3372-3375	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-10	3376-3385	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-11	3386-3387	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-12	3388-3392	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-13	3393-3394	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
21-14	3395-3397	to	_
21-15	3398-3405	exclude	_
21-16	3406-3411	those	_
21-17	3412-3416	with	_
21-18	3417-3418	a	_
21-19	3419-3426	history	_
21-20	3427-3429	of	_
21-21	3430-3432	an	_
21-22	3433-3437	Axis	_
21-23	3438-3439	1	_
21-24	3440-3448	disorder	_
21-25	3449-3451	or	_
21-26	3452-3464	first-degree	_
21-27	3465-3474	relatives	_
21-28	3475-3479	with	_
21-29	3480-3481	a	_
21-30	3482-3491	psychotic	_
21-31	3492-3500	disorder	_
21-32	3501-3502	.	_

Text=All participants tested negative on a urine drug screen test immediately prior to completion of the study.
22-1	3503-3506	All	_
22-2	3507-3519	participants	_
22-3	3520-3526	tested	_
22-4	3527-3535	negative	_
22-5	3536-3538	on	_
22-6	3539-3540	a	_
22-7	3541-3546	urine	_
22-8	3547-3551	drug	_
22-9	3552-3558	screen	_
22-10	3559-3563	test	_
22-11	3564-3575	immediately	_
22-12	3576-3581	prior	_
22-13	3582-3584	to	_
22-14	3585-3595	completion	_
22-15	3596-3598	of	_
22-16	3599-3602	the	_
22-17	3603-3608	study	_
22-18	3609-3610	.	_

Text=See Table 2 for additional demographic information.
23-1	3611-3614	See	_
23-2	3615-3620	Table	_
23-3	3621-3622	2	_
23-4	3623-3626	for	_
23-5	3627-3637	additional	_
23-6	3638-3649	demographic	_
23-7	3650-3661	information	_
23-8	3662-3663	.	_

Text=Clinical and Functional Characteristics Clinicians conducted all diagnostic evaluations, and diagnoses were confirmed by consensus conference.
24-1	3664-3672	Clinical	_
24-2	3673-3676	and	_
24-3	3677-3687	Functional	_
24-4	3688-3703	Characteristics	_
24-5	3704-3714	Clinicians	_
24-6	3715-3724	conducted	_
24-7	3725-3728	all	_
24-8	3729-3739	diagnostic	_
24-9	3740-3751	evaluations	_
24-10	3752-3753	,	_
24-11	3754-3757	and	_
24-12	3758-3767	diagnoses	_
24-13	3768-3772	were	_
24-14	3773-3782	confirmed	_
24-15	3783-3785	by	_
24-16	3786-3795	consensus	_
24-17	3796-3806	conference	_
24-18	3807-3808	.	_

Text=All clinicians had demonstrated reliability, defined by>.8 intra-class correlation-coefficients for continuous measures, and kappa>.7 for categorical measures; all participated in monthly reliability checks to prevent drift from these standards.
25-1	3809-3812	All	_
25-2	3813-3823	clinicians	_
25-3	3824-3827	had	_
25-4	3828-3840	demonstrated	_
25-5	3841-3852	reliability	_
25-6	3853-3854	,	_
25-7	3855-3862	defined	_
25-8	3863-3865	by	_
25-9	3866-3867	>	_
25-10	3868-3870	.8	_
25-11	3871-3882	intra-class	_
25-12	3883-3907	correlation-coefficients	_
25-13	3908-3911	for	_
25-14	3912-3922	continuous	_
25-15	3923-3931	measures	_
25-16	3932-3933	,	_
25-17	3934-3937	and	_
25-18	3938-3943	kappa	_
25-19	3944-3945	>	_
25-20	3946-3948	.7	_
25-21	3949-3952	for	_
25-22	3953-3964	categorical	_
25-23	3965-3973	measures	_
25-24	3974-3975	;	_
25-25	3976-3979	all	_
25-26	3980-3992	participated	_
25-27	3993-3995	in	_
25-28	3996-4003	monthly	_
25-29	4004-4015	reliability	_
25-30	4016-4022	checks	_
25-31	4023-4025	to	_
25-32	4026-4033	prevent	_
25-33	4034-4039	drift	_
25-34	4040-4044	from	_
25-35	4045-4050	these	_
25-36	4051-4060	standards	_
25-37	4061-4062	.	_

Text=Clinical symptom scores were measured using the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS).
26-1	4063-4071	Clinical	_
26-2	4072-4079	symptom	_
26-3	4080-4086	scores	_
26-4	4087-4091	were	_
26-5	4092-4100	measured	_
26-6	4101-4106	using	_
26-7	4107-4110	the	_
26-8	4111-4117	Scales	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-9	4118-4121	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-10	4122-4125	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-11	4126-4136	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-12	4137-4139	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-13	4140-4148	Positive	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-14	4149-4152	and	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-15	4153-4161	Negative	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-16	4162-4170	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-17	4171-4172	(	_
26-18	4173-4177	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-19	4178-4181	and	_
26-20	4182-4186	SANS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-21	4187-4188	)	_
26-22	4189-4190	.	_

Text=EEG Task Stimuli The stimuli consisted of 80 story sets.
27-1	4191-4194	EEG	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-2	4195-4199	Task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-3	4200-4207	Stimuli	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-4	4208-4211	The	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-5	4212-4219	stimuli	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-6	4220-4229	consisted	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-7	4230-4232	of	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-8	4233-4235	80	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-9	4236-4241	story	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-10	4242-4246	sets	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
27-11	4247-4248	.	_

Text=A set was comprised of two conditions of the same story: Animate and Inanimate.
28-1	4249-4250	A	_
28-2	4251-4254	set	_
28-3	4255-4258	was	_
28-4	4259-4268	comprised	_
28-5	4269-4271	of	_
28-6	4272-4275	two	_
28-7	4276-4286	conditions	_
28-8	4287-4289	of	_
28-9	4290-4293	the	_
28-10	4294-4298	same	_
28-11	4299-4304	story	_
28-12	4305-4306	:	_
28-13	4307-4314	Animate	_
28-14	4315-4318	and	_
28-15	4319-4328	Inanimate	_
28-16	4329-4330	.	_

Text=Stories were translated from Dutch to English and adapted for the purposes of the current study from those used in.
29-1	4331-4338	Stories	_
29-2	4339-4343	were	_
29-3	4344-4354	translated	_
29-4	4355-4359	from	_
29-5	4360-4365	Dutch	_
29-6	4366-4368	to	_
29-7	4369-4376	English	_
29-8	4377-4380	and	_
29-9	4381-4388	adapted	_
29-10	4389-4392	for	_
29-11	4393-4396	the	_
29-12	4397-4405	purposes	_
29-13	4406-4408	of	_
29-14	4409-4412	the	_
29-15	4413-4420	current	_
29-16	4421-4426	study	_
29-17	4427-4431	from	_
29-18	4432-4437	those	_
29-19	4438-4442	used	_
29-20	4443-4445	in	_
29-21	4446-4447	.	_

Text=Each story contained 4 sentences.
30-1	4448-4452	Each	_
30-2	4453-4458	story	_
30-3	4459-4468	contained	_
30-4	4469-4470	4	_
30-5	4471-4480	sentences	_
30-6	4481-4482	.	_

Text=For all stories, an inanimate, cartoon-like character was introduced in the first sentence (e.g.
31-1	4483-4486	For	_
31-2	4487-4490	all	_
31-3	4491-4498	stories	_
31-4	4499-4500	,	_
31-5	4501-4503	an	_
31-6	4504-4513	inanimate	_
31-7	4514-4515	,	_
31-8	4516-4528	cartoon-like	_
31-9	4529-4538	character	_
31-10	4539-4542	was	_
31-11	4543-4553	introduced	_
31-12	4554-4556	in	_
31-13	4557-4560	the	_
31-14	4561-4566	first	_
31-15	4567-4575	sentence	_
31-16	4576-4577	(	_
31-17	4578-4581	e.g	_
31-18	4582-4583	.	_

Text=a peanut that is described as happy and smiling).
32-1	4584-4585	a	_
32-2	4586-4592	peanut	_
32-3	4593-4597	that	_
32-4	4598-4600	is	_
32-5	4601-4610	described	_
32-6	4611-4613	as	_
32-7	4614-4619	happy	_
32-8	4620-4623	and	_
32-9	4624-4631	smiling	_
32-10	4632-4633	)	_
32-11	4634-4635	.	_

Text=The passages were written so that each sentence reinforced that the normally inanimate object (e.g., the peanut) served as an animate character in this context.
33-1	4636-4639	The	_
33-2	4640-4648	passages	_
33-3	4649-4653	were	_
33-4	4654-4661	written	_
33-5	4662-4664	so	_
33-6	4665-4669	that	_
33-7	4670-4674	each	_
33-8	4675-4683	sentence	_
33-9	4684-4694	reinforced	_
33-10	4695-4699	that	_
33-11	4700-4703	the	_
33-12	4704-4712	normally	_
33-13	4713-4722	inanimate	_
33-14	4723-4729	object	_
33-15	4730-4731	(	_
33-16	4732-4736	e.g.	_
33-17	4737-4738	,	_
33-18	4739-4742	the	_
33-19	4743-4749	peanut	_
33-20	4750-4751	)	_
33-21	4752-4758	served	_
33-22	4759-4761	as	_
33-23	4762-4764	an	_
33-24	4765-4772	animate	_
33-25	4773-4782	character	_
33-26	4783-4785	in	_
33-27	4786-4790	this	_
33-28	4791-4798	context	_
33-29	4799-4800	.	_

Text=This was accomplished by references in the first three sentences to the character using pronouns reserved for animate characters (he/she), and by the use of verbs and descriptions likewise reserved for animate characters (e.g.
34-1	4801-4805	This	_
34-2	4806-4809	was	_
34-3	4810-4822	accomplished	_
34-4	4823-4825	by	_
34-5	4826-4836	references	_
34-6	4837-4839	in	_
34-7	4840-4843	the	_
34-8	4844-4849	first	_
34-9	4850-4855	three	_
34-10	4856-4865	sentences	_
34-11	4866-4868	to	_
34-12	4869-4872	the	_
34-13	4873-4882	character	_
34-14	4883-4888	using	_
34-15	4889-4897	pronouns	_
34-16	4898-4906	reserved	_
34-17	4907-4910	for	_
34-18	4911-4918	animate	_
34-19	4919-4929	characters	_
34-20	4930-4931	(	_
34-21	4932-4938	he/she	_
34-22	4939-4940	)	_
34-23	4941-4942	,	_
34-24	4943-4946	and	_
34-25	4947-4949	by	_
34-26	4950-4953	the	_
34-27	4954-4957	use	_
34-28	4958-4960	of	_
34-29	4961-4966	verbs	_
34-30	4967-4970	and	_
34-31	4971-4983	descriptions	_
34-32	4984-4992	likewise	_
34-33	4993-5001	reserved	_
34-34	5002-5005	for	_
34-35	5006-5013	animate	_
34-36	5014-5024	characters	_
34-37	5025-5026	(	_
34-38	5027-5030	e.g	_
34-39	5031-5032	.	_

Text=the peanut had a big smile…; the peanut was amazed…).
35-1	5033-5036	the	_
35-2	5037-5043	peanut	_
35-3	5044-5047	had	_
35-4	5048-5049	a	_
35-5	5050-5053	big	_
35-6	5054-5060	smile…	_
35-7	5061-5062	;	_
35-8	5063-5066	the	_
35-9	5067-5073	peanut	_
35-10	5074-5077	was	_
35-11	5078-5085	amazed…	_
35-12	5086-5087	)	_
35-13	5088-5089	.	_

Text=Then, in sentence 4, the character was described using a critical word that requires an animate or inanimate object to fill one of its thematic roles.
36-1	5090-5094	Then	_
36-2	5095-5096	,	_
36-3	5097-5099	in	_
36-4	5100-5108	sentence	_
36-5	5109-5110	4	_
36-6	5111-5112	,	_
36-7	5113-5116	the	_
36-8	5117-5126	character	_
36-9	5127-5130	was	_
36-10	5131-5140	described	_
36-11	5141-5146	using	_
36-12	5147-5148	a	_
36-13	5149-5157	critical	_
36-14	5158-5162	word	_
36-15	5163-5167	that	_
36-16	5168-5176	requires	_
36-17	5177-5179	an	_
36-18	5180-5187	animate	_
36-19	5188-5190	or	_
36-20	5191-5200	inanimate	_
36-21	5201-5207	object	_
36-22	5208-5210	to	_
36-23	5211-5215	fill	_
36-24	5216-5219	one	_
36-25	5220-5222	of	_
36-26	5223-5226	its	_
36-27	5227-5235	thematic	_
36-28	5236-5241	roles	_
36-29	5242-5243	.	_

Text=This critical word was therefore consistent with either the immediately preceding context (cartoon-style context-Animate critical word), or inconsistent (cartoon-style context-Inanimate critical word).
37-1	5244-5248	This	_
37-2	5249-5257	critical	_
37-3	5258-5262	word	_
37-4	5263-5266	was	_
37-5	5267-5276	therefore	_
37-6	5277-5287	consistent	_
37-7	5288-5292	with	_
37-8	5293-5299	either	_
37-9	5300-5303	the	_
37-10	5304-5315	immediately	_
37-11	5316-5325	preceding	_
37-12	5326-5333	context	_
37-13	5334-5335	(	_
37-14	5336-5349	cartoon-style	_
37-15	5350-5365	context-Animate	_
37-16	5366-5374	critical	_
37-17	5375-5379	word	_
37-18	5380-5381	)	_
37-19	5382-5383	,	_
37-20	5384-5386	or	_
37-21	5387-5399	inconsistent	_
37-22	5400-5401	(	_
37-23	5402-5415	cartoon-style	_
37-24	5416-5433	context-Inanimate	_
37-25	5434-5442	critical	_
37-26	5443-5447	word	_
37-27	5448-5449	)	_
37-28	5450-5451	.	_

Text=Inanimate critical words were chosen to be consistent with the most typical, non-cartoon-style meaning of the inanimate objects that served as the animate character.
38-1	5452-5461	Inanimate	_
38-2	5462-5470	critical	_
38-3	5471-5476	words	_
38-4	5477-5481	were	_
38-5	5482-5488	chosen	_
38-6	5489-5491	to	_
38-7	5492-5494	be	_
38-8	5495-5505	consistent	_
38-9	5506-5510	with	_
38-10	5511-5514	the	_
38-11	5515-5519	most	_
38-12	5520-5527	typical	_
38-13	5528-5529	,	_
38-14	5530-5547	non-cartoon-style	_
38-15	5548-5555	meaning	_
38-16	5556-5558	of	_
38-17	5559-5562	the	_
38-18	5563-5572	inanimate	_
38-19	5573-5580	objects	_
38-20	5581-5585	that	_
38-21	5586-5592	served	_
38-22	5593-5595	as	_
38-23	5596-5599	the	_
38-24	5600-5607	animate	_
38-25	5608-5617	character	_
38-26	5618-5619	.	_

Text=See Table 1 for an example.
39-1	5620-5623	See	_
39-2	5624-5629	Table	_
39-3	5630-5631	1	_
39-4	5632-5635	for	_
39-5	5636-5638	an	_
39-6	5639-5646	example	_
39-7	5647-5648	.	_

Text=The critical words (e.g.
40-1	5649-5652	The	_
40-2	5653-5661	critical	_
40-3	5662-5667	words	_
40-4	5668-5669	(	_
40-5	5670-5673	e.g	_
40-6	5674-5675	.	_

Text=elated, salted) were matched in lexical frequency, length and number of syllables across conditions1.
41-1	5676-5682	elated	_
41-2	5683-5684	,	_
41-3	5685-5691	salted	_
41-4	5692-5693	)	_
41-5	5694-5698	were	_
41-6	5699-5706	matched	_
41-7	5707-5709	in	_
41-8	5710-5717	lexical	_
41-9	5718-5727	frequency	_
41-10	5728-5729	,	_
41-11	5730-5736	length	_
41-12	5737-5740	and	_
41-13	5741-5747	number	_
41-14	5748-5750	of	_
41-15	5751-5760	syllables	_
41-16	5761-5767	across	_
41-17	5768-5779	conditions1	_
41-18	5780-5781	.	_

Text=To measure lexical frequency, we used LG10CD values from the SUBTLEXus database (http: //expsy.ugent.be/subtlexus).
42-1	5782-5784	To	_
42-2	5785-5792	measure	_
42-3	5793-5800	lexical	_
42-4	5801-5810	frequency	_
42-5	5811-5812	,	_
42-6	5813-5815	we	_
42-7	5816-5820	used	_
42-8	5821-5827	LG10CD	_
42-9	5828-5834	values	_
42-10	5835-5839	from	_
42-11	5840-5843	the	_
42-12	5844-5853	SUBTLEXus	_
42-13	5854-5862	database	_
42-14	5863-5864	(	_
42-15	5865-5869	http	_
42-16	5870-5871	:	_
42-17	5872-5898	//expsy.ugent.be/subtlexus	_
42-18	5899-5900	)	_
42-19	5901-5902	.	_

Text=The average LG10CD lexical frequency value for critical words in the Animate condition was 1.94 (SD: .62), and 1.8 (SD: .66) in the Inanimate condition.
43-1	5903-5906	The	_
43-2	5907-5914	average	_
43-3	5915-5921	LG10CD	_
43-4	5922-5929	lexical	_
43-5	5930-5939	frequency	_
43-6	5940-5945	value	_
43-7	5946-5949	for	_
43-8	5950-5958	critical	_
43-9	5959-5964	words	_
43-10	5965-5967	in	_
43-11	5968-5971	the	_
43-12	5972-5979	Animate	_
43-13	5980-5989	condition	_
43-14	5990-5993	was	_
43-15	5994-5998	1.94	_
43-16	5999-6000	(	_
43-17	6001-6003	SD	_
43-18	6004-6005	:	_
43-19	6006-6009	.62	_
43-20	6010-6011	)	_
43-21	6012-6013	,	_
43-22	6014-6017	and	_
43-23	6018-6021	1.8	_
43-24	6022-6023	(	_
43-25	6024-6026	SD	_
43-26	6027-6028	:	_
43-27	6029-6032	.66	_
43-28	6033-6034	)	_
43-29	6035-6037	in	_
43-30	6038-6041	the	_
43-31	6042-6051	Inanimate	_
43-32	6052-6061	condition	_
43-33	6062-6063	.	_

Text=Critical words were also matched in length and number of syllables.
44-1	6064-6072	Critical	_
44-2	6073-6078	words	_
44-3	6079-6083	were	_
44-4	6084-6088	also	_
44-5	6089-6096	matched	_
44-6	6097-6099	in	_
44-7	6100-6106	length	_
44-8	6107-6110	and	_
44-9	6111-6117	number	_
44-10	6118-6120	of	_
44-11	6121-6130	syllables	_
44-12	6131-6132	.	_

Text=The average length of Animate critical words was 7.9 characters (SD: 1.7), and 7.5 (SD: 1.9) for Inanimate critical words.
45-1	6133-6136	The	_
45-2	6137-6144	average	_
45-3	6145-6151	length	_
45-4	6152-6154	of	_
45-5	6155-6162	Animate	_
45-6	6163-6171	critical	_
45-7	6172-6177	words	_
45-8	6178-6181	was	_
45-9	6182-6185	7.9	_
45-10	6186-6196	characters	_
45-11	6197-6198	(	_
45-12	6199-6201	SD	_
45-13	6202-6203	:	_
45-14	6204-6207	1.7	_
45-15	6208-6209	)	_
45-16	6210-6211	,	_
45-17	6212-6215	and	_
45-18	6216-6219	7.5	_
45-19	6220-6221	(	_
45-20	6222-6224	SD	_
45-21	6225-6226	:	_
45-22	6227-6230	1.9	_
45-23	6231-6232	)	_
45-24	6233-6236	for	_
45-25	6237-6246	Inanimate	_
45-26	6247-6255	critical	_
45-27	6256-6261	words	_
45-28	6262-6263	.	_

Text=The average number of syllables of Animate critical words was 2.6 (SD: 0.8), and 2.4 (SD: 0.84) for Inanimate critical words.
46-1	6264-6267	The	_
46-2	6268-6275	average	_
46-3	6276-6282	number	_
46-4	6283-6285	of	_
46-5	6286-6295	syllables	_
46-6	6296-6298	of	_
46-7	6299-6306	Animate	_
46-8	6307-6315	critical	_
46-9	6316-6321	words	_
46-10	6322-6325	was	_
46-11	6326-6329	2.6	_
46-12	6330-6331	(	_
46-13	6332-6334	SD	_
46-14	6335-6336	:	_
46-15	6337-6340	0.8	_
46-16	6341-6342	)	_
46-17	6343-6344	,	_
46-18	6345-6348	and	_
46-19	6349-6352	2.4	_
46-20	6353-6354	(	_
46-21	6355-6357	SD	_
46-22	6358-6359	:	_
46-23	6360-6364	0.84	_
46-24	6365-6366	)	_
46-25	6367-6370	for	_
46-26	6371-6380	Inanimate	_
46-27	6381-6389	critical	_
46-28	6390-6395	words	_
46-29	6396-6397	.	_

Text=Stimuli were recorded for auditory presentation by a female speaker, using a natural inflection and speaking rate.
47-1	6398-6405	Stimuli	_
47-2	6406-6410	were	_
47-3	6411-6419	recorded	_
47-4	6420-6423	for	_
47-5	6424-6432	auditory	_
47-6	6433-6445	presentation	_
47-7	6446-6448	by	_
47-8	6449-6450	a	_
47-9	6451-6457	female	_
47-10	6458-6465	speaker	_
47-11	6466-6467	,	_
47-12	6468-6473	using	_
47-13	6474-6475	a	_
47-14	6476-6483	natural	_
47-15	6484-6494	inflection	_
47-16	6495-6498	and	_
47-17	6499-6507	speaking	_
47-18	6508-6512	rate	_
47-19	6513-6514	.	_

Text=The first three sentences of each passage, which comprised the discourse context for the fourth sentence (which contained the critical words), were recorded separately from the critical fourth sentences.
48-1	6515-6518	The	_
48-2	6519-6524	first	_
48-3	6525-6530	three	_
48-4	6531-6540	sentences	_
48-5	6541-6543	of	_
48-6	6544-6548	each	_
48-7	6549-6556	passage	_
48-8	6557-6558	,	_
48-9	6559-6564	which	_
48-10	6565-6574	comprised	_
48-11	6575-6578	the	_
48-12	6579-6588	discourse	_
48-13	6589-6596	context	_
48-14	6597-6600	for	_
48-15	6601-6604	the	_
48-16	6605-6611	fourth	_
48-17	6612-6620	sentence	_
48-18	6621-6622	(	_
48-19	6623-6628	which	_
48-20	6629-6638	contained	_
48-21	6639-6642	the	_
48-22	6643-6651	critical	_
48-23	6652-6657	words	_
48-24	6658-6659	)	_
48-25	6660-6661	,	_
48-26	6662-6666	were	_
48-27	6667-6675	recorded	_
48-28	6676-6686	separately	_
48-29	6687-6691	from	_
48-30	6692-6695	the	_
48-31	6696-6704	critical	_
48-32	6705-6711	fourth	_
48-33	6712-6721	sentences	_
48-34	6722-6723	.	_

Text=The onset and offset of all critical words were determined by visual inspection of the speech waveform and by listening to the waveforms using speech-editing software (Audacity, by Soundforge).
49-1	6724-6727	The	_
49-2	6728-6733	onset	_
49-3	6734-6737	and	_
49-4	6738-6744	offset	_
49-5	6745-6747	of	_
49-6	6748-6751	all	_
49-7	6752-6760	critical	_
49-8	6761-6766	words	_
49-9	6767-6771	were	_
49-10	6772-6782	determined	_
49-11	6783-6785	by	_
49-12	6786-6792	visual	_
49-13	6793-6803	inspection	_
49-14	6804-6806	of	_
49-15	6807-6810	the	_
49-16	6811-6817	speech	_
49-17	6818-6826	waveform	_
49-18	6827-6830	and	_
49-19	6831-6833	by	_
49-20	6834-6843	listening	_
49-21	6844-6846	to	_
49-22	6847-6850	the	_
49-23	6851-6860	waveforms	_
49-24	6861-6866	using	_
49-25	6867-6881	speech-editing	_
49-26	6882-6890	software	_
49-27	6891-6892	(	_
49-28	6893-6901	Audacity	_
49-29	6902-6903	,	_
49-30	6904-6906	by	_
49-31	6907-6917	Soundforge	_
49-32	6918-6919	)	_
49-33	6920-6921	.	_

Text=The average duration of the critical words was 637.6 ms (range: 366- 974 ms); the critical words did not differ in duration between conditions (p=.4).
50-1	6922-6925	The	_
50-2	6926-6933	average	_
50-3	6934-6942	duration	_
50-4	6943-6945	of	_
50-5	6946-6949	the	_
50-6	6950-6958	critical	_
50-7	6959-6964	words	_
50-8	6965-6968	was	_
50-9	6969-6974	637.6	_
50-10	6975-6977	ms	_
50-11	6978-6979	(	_
50-12	6980-6985	range	_
50-13	6986-6987	:	_
50-14	6988-6992	366-	_
50-15	6993-6996	974	_
50-16	6997-6999	ms	_
50-17	7000-7001	)	_
50-18	7002-7003	;	_
50-19	7004-7007	the	_
50-20	7008-7016	critical	_
50-21	7017-7022	words	_
50-22	7023-7026	did	_
50-23	7027-7030	not	_
50-24	7031-7037	differ	_
50-25	7038-7040	in	_
50-26	7041-7049	duration	_
50-27	7050-7057	between	_
50-28	7058-7068	conditions	_
50-29	7069-7070	(	_
50-30	7071-7075	p=.4	_
50-31	7076-7077	)	_
50-32	7078-7079	.	_

Text=One hundred and sixty filler stories of comparable length and structure were also included.
51-1	7080-7083	One	_
51-2	7084-7091	hundred	_
51-3	7092-7095	and	_
51-4	7096-7101	sixty	_
51-5	7102-7108	filler	_
51-6	7109-7116	stories	_
51-7	7117-7119	of	_
51-8	7120-7130	comparable	_
51-9	7131-7137	length	_
51-10	7138-7141	and	_
51-11	7142-7151	structure	_
51-12	7152-7156	were	_
51-13	7157-7161	also	_
51-14	7162-7170	included	_
51-15	7171-7172	.	_

Text=These served as experimental stories for a separate study, and also consisted of spoken 4-sentence stories, but did not feature cartoon-style protagonists.
52-1	7173-7178	These	_
52-2	7179-7185	served	_
52-3	7186-7188	as	_
52-4	7189-7201	experimental	_
52-5	7202-7209	stories	_
52-6	7210-7213	for	_
52-7	7214-7215	a	_
52-8	7216-7224	separate	_
52-9	7225-7230	study	_
52-10	7231-7232	,	_
52-11	7233-7236	and	_
52-12	7237-7241	also	_
52-13	7242-7251	consisted	_
52-14	7252-7254	of	_
52-15	7255-7261	spoken	_
52-16	7262-7272	4-sentence	_
52-17	7273-7280	stories	_
52-18	7281-7282	,	_
52-19	7283-7286	but	_
52-20	7287-7290	did	_
52-21	7291-7294	not	_
52-22	7295-7302	feature	_
52-23	7303-7316	cartoon-style	_
52-24	7317-7329	protagonists	_
52-25	7330-7331	.	_

Text=Instead, the filler stories featured canonically animate protagonists in non-anomalous scenarios (e.g.
53-1	7332-7339	Instead	_
53-2	7340-7341	,	_
53-3	7342-7345	the	_
53-4	7346-7352	filler	_
53-5	7353-7360	stories	_
53-6	7361-7369	featured	_
53-7	7370-7381	canonically	_
53-8	7382-7389	animate	_
53-9	7390-7402	protagonists	_
53-10	7403-7405	in	_
53-11	7406-7419	non-anomalous	_
53-12	7420-7429	scenarios	_
53-13	7430-7431	(	_
53-14	7432-7435	e.g	_
53-15	7436-7437	.	_

Text=a seamstress mending clothes).
54-1	7438-7439	a	_
54-2	7440-7450	seamstress	_
54-3	7451-7458	mending	_
54-4	7459-7466	clothes	_
54-5	7467-7468	)	_
54-6	7469-7470	.	_

Text=These stories included a syntactic manipulation in which a prepositional phrase in the fourth sentence attached to the main verb or attached to the direct object (e.g.
55-1	7471-7476	These	_
55-2	7477-7484	stories	_
55-3	7485-7493	included	_
55-4	7494-7495	a	_
55-5	7496-7505	syntactic	_
55-6	7506-7518	manipulation	_
55-7	7519-7521	in	_
55-8	7522-7527	which	_
55-9	7528-7529	a	_
55-10	7530-7543	prepositional	_
55-11	7544-7550	phrase	_
55-12	7551-7553	in	_
55-13	7554-7557	the	_
55-14	7558-7564	fourth	_
55-15	7565-7573	sentence	_
55-16	7574-7582	attached	_
55-17	7583-7585	to	_
55-18	7586-7589	the	_
55-19	7590-7594	main	_
55-20	7595-7599	verb	_
55-21	7600-7602	or	_
55-22	7603-7611	attached	_
55-23	7612-7614	to	_
55-24	7615-7618	the	_
55-25	7619-7625	direct	_
55-26	7626-7632	object	_
55-27	7633-7634	(	_
55-28	7635-7638	e.g	_
55-29	7639-7640	.	_

Text=repaired the sock with the thread/hole).
56-1	7641-7649	repaired	_
56-2	7650-7653	the	_
56-3	7654-7658	sock	_
56-4	7659-7663	with	_
56-5	7664-7667	the	_
56-6	7668-7679	thread/hole	_
56-7	7680-7681	)	_
56-8	7682-7683	.	_

Text=Comprehension questions followed all stories (experimental items and fillers).
57-1	7684-7697	Comprehension	_
57-2	7698-7707	questions	_
57-3	7708-7716	followed	_
57-4	7717-7720	all	_
57-5	7721-7728	stories	_
57-6	7729-7730	(	_
57-7	7731-7743	experimental	_
57-8	7744-7749	items	_
57-9	7750-7753	and	_
57-10	7754-7761	fillers	_
57-11	7762-7763	)	_
57-12	7764-7765	.	_

Text=The correct answer to half of the questions was true, whereas the correct answer to the other half was false.
58-1	7766-7769	The	_
58-2	7770-7777	correct	_
58-3	7778-7784	answer	_
58-4	7785-7787	to	_
58-5	7788-7792	half	_
58-6	7793-7795	of	_
58-7	7796-7799	the	_
58-8	7800-7809	questions	_
58-9	7810-7813	was	_
58-10	7814-7818	true	_
58-11	7819-7820	,	_
58-12	7821-7828	whereas	_
58-13	7829-7832	the	_
58-14	7833-7840	correct	_
58-15	7841-7847	answer	_
58-16	7848-7850	to	_
58-17	7851-7854	the	_
58-18	7855-7860	other	_
58-19	7861-7865	half	_
58-20	7866-7869	was	_
58-21	7870-7875	false	_
58-22	7876-7877	.	_

Text=Stimuli were divided into four lists for presentation, such that each list contained 40 stories in each condition (Animate, Inanimate), and no list contained both conditions of the same item.
59-1	7878-7885	Stimuli	_
59-2	7886-7890	were	_
59-3	7891-7898	divided	_
59-4	7899-7903	into	_
59-5	7904-7908	four	_
59-6	7909-7914	lists	_
59-7	7915-7918	for	_
59-8	7919-7931	presentation	_
59-9	7932-7933	,	_
59-10	7934-7938	such	_
59-11	7939-7943	that	_
59-12	7944-7948	each	_
59-13	7949-7953	list	_
59-14	7954-7963	contained	_
59-15	7964-7966	40	_
59-16	7967-7974	stories	_
59-17	7975-7977	in	_
59-18	7978-7982	each	_
59-19	7983-7992	condition	_
59-20	7993-7994	(	_
59-21	7995-8002	Animate	_
59-22	8003-8004	,	_
59-23	8005-8014	Inanimate	_
59-24	8015-8016	)	_
59-25	8017-8018	,	_
59-26	8019-8022	and	_
59-27	8023-8025	no	_
59-28	8026-8030	list	_
59-29	8031-8040	contained	_
59-30	8041-8045	both	_
59-31	8046-8056	conditions	_
59-32	8057-8059	of	_
59-33	8060-8063	the	_
59-34	8064-8068	same	_
59-35	8069-8073	item	_
59-36	8074-8075	.	_

Text=Stimuli for Behavioral Tasks In addition to the EEG task, participants completed three behavioral tasks designed to assess vocabulary, working memory, and cognitive control (the Nelson-Denny vocabulary test, Listening Span, and the AX-CPT, respectively).
60-1	8076-8083	Stimuli	http://maven.renci.org/NeuroBridge/neurobridge#BehavioralActivationScale
60-2	8084-8087	for	http://maven.renci.org/NeuroBridge/neurobridge#BehavioralActivationScale
60-3	8088-8098	Behavioral	http://maven.renci.org/NeuroBridge/neurobridge#BehavioralActivationScale
60-4	8099-8104	Tasks	http://maven.renci.org/NeuroBridge/neurobridge#BehavioralActivationScale
60-5	8105-8107	In	_
60-6	8108-8116	addition	_
60-7	8117-8119	to	_
60-8	8120-8123	the	_
60-9	8124-8127	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
60-10	8128-8132	task	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
60-11	8133-8134	,	_
60-12	8135-8147	participants	_
60-13	8148-8157	completed	_
60-14	8158-8163	three	_
60-15	8164-8174	behavioral	_
60-16	8175-8180	tasks	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
60-17	8181-8189	designed	_
60-18	8190-8192	to	_
60-19	8193-8199	assess	_
60-20	8200-8210	vocabulary	_
60-21	8211-8212	,	_
60-22	8213-8220	working	_
60-23	8221-8227	memory	_
60-24	8228-8229	,	_
60-25	8230-8233	and	_
60-26	8234-8243	cognitive	_
60-27	8244-8251	control	_
60-28	8252-8253	(	_
60-29	8254-8257	the	_
60-30	8258-8270	Nelson-Denny	_
60-31	8271-8281	vocabulary	http://maven.renci.org/NeuroBridge/neurobridge#GlucoseToleranceTest
60-32	8282-8286	test	http://maven.renci.org/NeuroBridge/neurobridge#GlucoseToleranceTest
60-33	8287-8288	,	_
60-34	8289-8298	Listening	_
60-35	8299-8303	Span	http://maven.renci.org/NeuroBridge/neurobridge#SpanishEnglishVerbalLearningTest
60-36	8304-8305	,	_
60-37	8306-8309	and	_
60-38	8310-8313	the	_
60-39	8314-8320	AX-CPT	http://maven.renci.org/NeuroBridge/neurobridge#Thing
60-40	8321-8322	,	_
60-41	8323-8335	respectively	_
60-42	8336-8337	)	_
60-43	8338-8339	.	_

Text=All participants completed the vocabulary section of the Nelson-Denny Reading Test, a standardized paper and pencil multiple-choice assessment.
61-1	8340-8343	All	_
61-2	8344-8356	participants	_
61-3	8357-8366	completed	_
61-4	8367-8370	the	_
61-5	8371-8381	vocabulary	_
61-6	8382-8389	section	_
61-7	8390-8392	of	_
61-8	8393-8396	the	_
61-9	8397-8409	Nelson-Denny	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
61-10	8410-8417	Reading	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
61-11	8418-8422	Test	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
61-12	8423-8424	,	_
61-13	8425-8426	a	_
61-14	8427-8439	standardized	_
61-15	8440-8445	paper	_
61-16	8446-8449	and	_
61-17	8450-8456	pencil	_
61-18	8457-8472	multiple-choice	_
61-19	8473-8483	assessment	_
61-20	8484-8485	.	_

Text=Participants were allotted 15 minutes to complete the section.
62-1	8486-8498	Participants	_
62-2	8499-8503	were	_
62-3	8504-8512	allotted	_
62-4	8513-8515	15	_
62-5	8516-8523	minutes	_
62-6	8524-8526	to	_
62-7	8527-8535	complete	_
62-8	8536-8539	the	_
62-9	8540-8547	section	_
62-10	8548-8549	.	_

Text=Vocabulary is strongly predictive of language comprehension abilities and was employed in this study to examine individual variation in the ERP/EEG data that may be due to variability in verbal ability.
63-1	8550-8560	Vocabulary	_
63-2	8561-8563	is	_
63-3	8564-8572	strongly	_
63-4	8573-8583	predictive	_
63-5	8584-8586	of	_
63-6	8587-8595	language	_
63-7	8596-8609	comprehension	_
63-8	8610-8619	abilities	_
63-9	8620-8623	and	_
63-10	8624-8627	was	_
63-11	8628-8636	employed	_
63-12	8637-8639	in	_
63-13	8640-8644	this	_
63-14	8645-8650	study	_
63-15	8651-8653	to	_
63-16	8654-8661	examine	_
63-17	8662-8672	individual	_
63-18	8673-8682	variation	_
63-19	8683-8685	in	_
63-20	8686-8689	the	_
63-21	8690-8697	ERP/EEG	_
63-22	8698-8702	data	_
63-23	8703-8707	that	_
63-24	8708-8711	may	_
63-25	8712-8714	be	_
63-26	8715-8718	due	_
63-27	8719-8721	to	_
63-28	8722-8733	variability	_
63-29	8734-8736	in	_
63-30	8737-8743	verbal	_
63-31	8744-8751	ability	_
63-32	8752-8753	.	_

Text=Nelson-Denny vocabulary scores were calculated as the total percent correct for the vocabulary section, Form G (out of 80 possible).
64-1	8754-8766	Nelson-Denny	_
64-2	8767-8777	vocabulary	_
64-3	8778-8784	scores	_
64-4	8785-8789	were	_
64-5	8790-8800	calculated	_
64-6	8801-8803	as	_
64-7	8804-8807	the	_
64-8	8808-8813	total	_
64-9	8814-8821	percent	_
64-10	8822-8829	correct	_
64-11	8830-8833	for	_
64-12	8834-8837	the	_
64-13	8838-8848	vocabulary	_
64-14	8849-8856	section	_
64-15	8857-8858	,	_
64-16	8859-8863	Form	_
64-17	8864-8865	G	_
64-18	8866-8867	(	_
64-19	8868-8871	out	_
64-20	8872-8874	of	_
64-21	8875-8877	80	_
64-22	8878-8886	possible	_
64-23	8887-8888	)	_
64-24	8889-8890	.	_

Text=The Listening Span task was adapted from and consisted of 25 sets of sentences ranging from two to six sentences per set; there were five sets of each set size.
65-1	8891-8894	The	_
65-2	8895-8904	Listening	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
65-3	8905-8909	Span	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
65-4	8910-8914	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
65-5	8915-8918	was	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
65-6	8919-8926	adapted	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
65-7	8927-8931	from	_
65-8	8932-8935	and	_
65-9	8936-8945	consisted	http://maven.renci.org/NeuroBridge/neurobridge#QualityOfLifeQuestionnaire
65-10	8946-8948	of	http://maven.renci.org/NeuroBridge/neurobridge#QualityOfLifeQuestionnaire
65-11	8949-8951	25	_
65-12	8952-8956	sets	_
65-13	8957-8959	of	_
65-14	8960-8969	sentences	_
65-15	8970-8977	ranging	_
65-16	8978-8982	from	_
65-17	8983-8986	two	_
65-18	8987-8989	to	_
65-19	8990-8993	six	_
65-20	8994-9003	sentences	_
65-21	9004-9007	per	_
65-22	9008-9011	set	_
65-23	9012-9013	;	_
65-24	9014-9019	there	_
65-25	9020-9024	were	_
65-26	9025-9029	five	_
65-27	9030-9034	sets	_
65-28	9035-9037	of	_
65-29	9038-9042	each	_
65-30	9043-9046	set	_
65-31	9047-9051	size	_
65-32	9052-9053	.	_

Text=Participants were instructed to listen to all sentences within each set for comprehension and then to indicate whether each sentence was true or false immediately after hearing it.
66-1	9054-9066	Participants	_
66-2	9067-9071	were	_
66-3	9072-9082	instructed	_
66-4	9083-9085	to	_
66-5	9086-9092	listen	_
66-6	9093-9095	to	_
66-7	9096-9099	all	_
66-8	9100-9109	sentences	_
66-9	9110-9116	within	_
66-10	9117-9121	each	_
66-11	9122-9125	set	_
66-12	9126-9129	for	_
66-13	9130-9143	comprehension	_
66-14	9144-9147	and	_
66-15	9148-9152	then	_
66-16	9153-9155	to	_
66-17	9156-9164	indicate	_
66-18	9165-9172	whether	_
66-19	9173-9177	each	_
66-20	9178-9186	sentence	_
66-21	9187-9190	was	_
66-22	9191-9195	true	_
66-23	9196-9198	or	_
66-24	9199-9204	false	_
66-25	9205-9216	immediately	_
66-26	9217-9222	after	_
66-27	9223-9230	hearing	_
66-28	9231-9233	it	_
66-29	9234-9235	.	_

Text=In addition, participants were instructed to remember the final word of each sentence in the set and were asked to recall them in any order after the whole set was presented.
67-1	9236-9238	In	_
67-2	9239-9247	addition	_
67-3	9248-9249	,	_
67-4	9250-9262	participants	_
67-5	9263-9267	were	_
67-6	9268-9278	instructed	_
67-7	9279-9281	to	_
67-8	9282-9290	remember	_
67-9	9291-9294	the	_
67-10	9295-9300	final	_
67-11	9301-9305	word	_
67-12	9306-9308	of	_
67-13	9309-9313	each	_
67-14	9314-9322	sentence	_
67-15	9323-9325	in	_
67-16	9326-9329	the	_
67-17	9330-9333	set	_
67-18	9334-9337	and	_
67-19	9338-9342	were	_
67-20	9343-9348	asked	_
67-21	9349-9351	to	_
67-22	9352-9358	recall	_
67-23	9359-9363	them	_
67-24	9364-9366	in	_
67-25	9367-9370	any	_
67-26	9371-9376	order	_
67-27	9377-9382	after	_
67-28	9383-9386	the	_
67-29	9387-9392	whole	_
67-30	9393-9396	set	_
67-31	9397-9400	was	_
67-32	9401-9410	presented	_
67-33	9411-9412	.	_

Text=There was a 1500 ms pause between each sentence during which participants made their true/false response.
68-1	9413-9418	There	_
68-2	9419-9422	was	_
68-3	9423-9424	a	_
68-4	9425-9429	1500	_
68-5	9430-9432	ms	_
68-6	9433-9438	pause	_
68-7	9439-9446	between	_
68-8	9447-9451	each	_
68-9	9452-9460	sentence	_
68-10	9461-9467	during	_
68-11	9468-9473	which	_
68-12	9474-9486	participants	_
68-13	9487-9491	made	_
68-14	9492-9497	their	_
68-15	9498-9508	true/false	_
68-16	9509-9517	response	_
68-17	9518-9519	.	_

Text=Presentation of sets was random.
69-1	9520-9532	Presentation	_
69-2	9533-9535	of	_
69-3	9536-9540	sets	_
69-4	9541-9544	was	_
69-5	9545-9551	random	_
69-6	9552-9553	.	_

Text=Each correct response (accurate final word recall) was scored as one point, for a maximum of 100 points.
70-1	9554-9558	Each	_
70-2	9559-9566	correct	_
70-3	9567-9575	response	_
70-4	9576-9577	(	_
70-5	9578-9586	accurate	_
70-6	9587-9592	final	_
70-7	9593-9597	word	_
70-8	9598-9604	recall	_
70-9	9605-9606	)	_
70-10	9607-9610	was	_
70-11	9611-9617	scored	_
70-12	9618-9620	as	_
70-13	9621-9624	one	_
70-14	9625-9630	point	_
70-15	9631-9632	,	_
70-16	9633-9636	for	_
70-17	9637-9638	a	_
70-18	9639-9646	maximum	_
70-19	9647-9649	of	_
70-20	9650-9653	100	_
70-21	9654-9660	points	_
70-22	9661-9662	.	_

Text=The AX-CPT was designed to assess cognitive control mechanisms, specifically the ability to maintain task goals and task-relevant context.
71-1	9663-9666	The	_
71-2	9667-9673	AX-CPT	_
71-3	9674-9677	was	_
71-4	9678-9686	designed	_
71-5	9687-9689	to	_
71-6	9690-9696	assess	_
71-7	9697-9706	cognitive	_
71-8	9707-9714	control	_
71-9	9715-9725	mechanisms	_
71-10	9726-9727	,	_
71-11	9728-9740	specifically	_
71-12	9741-9744	the	_
71-13	9745-9752	ability	_
71-14	9753-9755	to	_
71-15	9756-9764	maintain	_
71-16	9765-9769	task	_
71-17	9770-9775	goals	_
71-18	9776-9779	and	_
71-19	9780-9793	task-relevant	_
71-20	9794-9801	context	_
71-21	9802-9803	.	_

Text=The version used here was developed as part of the CNTRACS (Cognitive Neuroscience Test Reliability and Clinical applications for Schizophrenia) initiative, and is freely available via the CNTRACS website (http: //cntracs.ucdavis.edu/task/dpx).
72-1	9804-9807	The	_
72-2	9808-9815	version	_
72-3	9816-9820	used	_
72-4	9821-9825	here	_
72-5	9826-9829	was	_
72-6	9830-9839	developed	_
72-7	9840-9842	as	_
72-8	9843-9847	part	_
72-9	9848-9850	of	_
72-10	9851-9854	the	_
72-11	9855-9862	CNTRACS	_
72-12	9863-9864	(	_
72-13	9865-9874	Cognitive	_
72-14	9875-9887	Neuroscience	_
72-15	9888-9892	Test	_
72-16	9893-9904	Reliability	_
72-17	9905-9908	and	_
72-18	9909-9917	Clinical	_
72-19	9918-9930	applications	_
72-20	9931-9934	for	_
72-21	9935-9948	Schizophrenia	_
72-22	9949-9950	)	_
72-23	9951-9961	initiative	_
72-24	9962-9963	,	_
72-25	9964-9967	and	_
72-26	9968-9970	is	_
72-27	9971-9977	freely	_
72-28	9978-9987	available	_
72-29	9988-9991	via	_
72-30	9992-9995	the	_
72-31	9996-10003	CNTRACS	_
72-32	10004-10011	website	_
72-33	10012-10013	(	_
72-34	10014-10018	http	_
72-35	10019-10020	:	_
72-36	10021-10051	//cntracs.ucdavis.edu/task/dpx	_
72-37	10052-10053	)	_
72-38	10054-10055	.	_

Text=In this task, participants respond to a series of letters via key press.
73-1	10056-10058	In	_
73-2	10059-10063	this	_
73-3	10064-10068	task	_
73-4	10069-10070	,	_
73-5	10071-10083	participants	_
73-6	10084-10091	respond	_
73-7	10092-10094	to	_
73-8	10095-10096	a	_
73-9	10097-10103	series	_
73-10	10104-10106	of	_
73-11	10107-10114	letters	_
73-12	10115-10118	via	_
73-13	10119-10122	key	_
73-14	10123-10128	press	_
73-15	10129-10130	.	_

Text=They are told to respond with their index finger only to the letter X (target) and only when the X is preceded by the letter A (cue); they are asked to respond with a middle finger button press to all other letters.
74-1	10131-10135	They	_
74-2	10136-10139	are	_
74-3	10140-10144	told	_
74-4	10145-10147	to	_
74-5	10148-10155	respond	_
74-6	10156-10160	with	_
74-7	10161-10166	their	_
74-8	10167-10172	index	_
74-9	10173-10179	finger	_
74-10	10180-10184	only	_
74-11	10185-10187	to	_
74-12	10188-10191	the	_
74-13	10192-10198	letter	_
74-14	10199-10200	X	_
74-15	10201-10202	(	_
74-16	10203-10209	target	_
74-17	10210-10211	)	_
74-18	10212-10215	and	_
74-19	10216-10220	only	_
74-20	10221-10225	when	_
74-21	10226-10229	the	_
74-22	10230-10231	X	_
74-23	10232-10234	is	_
74-24	10235-10243	preceded	_
74-25	10244-10246	by	_
74-26	10247-10250	the	_
74-27	10251-10257	letter	_
74-28	10258-10259	A	_
74-29	10260-10261	(	_
74-30	10262-10265	cue	_
74-31	10266-10267	)	_
74-32	10268-10269	;	_
74-33	10270-10274	they	_
74-34	10275-10278	are	_
74-35	10279-10284	asked	_
74-36	10285-10287	to	_
74-37	10288-10295	respond	_
74-38	10296-10300	with	_
74-39	10301-10302	a	_
74-40	10303-10309	middle	_
74-41	10310-10316	finger	_
74-42	10317-10323	button	_
74-43	10324-10329	press	_
74-44	10330-10332	to	_
74-45	10333-10336	all	_
74-46	10337-10342	other	_
74-47	10343-10350	letters	_
74-48	10351-10352	.	_

Text=A-X cue-probe target sequences are frequent (70%) and set up a tendency to make a target response when the letter X occurs.
75-1	10353-10356	A-X	_
75-2	10357-10366	cue-probe	_
75-3	10367-10373	target	_
75-4	10374-10383	sequences	_
75-5	10384-10387	are	_
75-6	10388-10396	frequent	_
75-7	10397-10398	(	_
75-8	10399-10401	70	_
75-9	10402-10403	%	_
75-10	10404-10405	)	_
75-11	10406-10409	and	_
75-12	10410-10413	set	_
75-13	10414-10416	up	_
75-14	10417-10418	a	_
75-15	10419-10427	tendency	_
75-16	10428-10430	to	_
75-17	10431-10435	make	_
75-18	10436-10437	a	_
75-19	10438-10444	target	_
75-20	10445-10453	response	_
75-21	10454-10458	when	_
75-22	10459-10462	the	_
75-23	10463-10469	letter	_
75-24	10470-10471	X	_
75-25	10472-10478	occurs	_
75-26	10479-10480	.	_

Text=Therefore, participants often make errors when the letter X appears, but was not preceded by an A (e.g., X preceded by the letter B).
76-1	10481-10490	Therefore	_
76-2	10491-10492	,	_
76-3	10493-10505	participants	_
76-4	10506-10511	often	_
76-5	10512-10516	make	_
76-6	10517-10523	errors	_
76-7	10524-10528	when	_
76-8	10529-10532	the	_
76-9	10533-10539	letter	_
76-10	10540-10541	X	_
76-11	10542-10549	appears	_
76-12	10550-10551	,	_
76-13	10552-10555	but	_
76-14	10556-10559	was	_
76-15	10560-10563	not	_
76-16	10564-10572	preceded	_
76-17	10573-10575	by	_
76-18	10576-10578	an	_
76-19	10579-10580	A	_
76-20	10581-10582	(	_
76-21	10583-10587	e.g.	_
76-22	10588-10589	,	_
76-23	10590-10591	X	_
76-24	10592-10600	preceded	_
76-25	10601-10603	by	_
76-26	10604-10607	the	_
76-27	10608-10614	letter	_
76-28	10615-10616	B	_
76-29	10617-10618	)	_
76-30	10619-10620	.	_

Text=Good performance involves the ability to attend to the context in which the letter X occurs and to maintain the task goal throughout processing.
77-1	10621-10625	Good	_
77-2	10626-10637	performance	_
77-3	10638-10646	involves	_
77-4	10647-10650	the	_
77-5	10651-10658	ability	_
77-6	10659-10661	to	_
77-7	10662-10668	attend	_
77-8	10669-10671	to	_
77-9	10672-10675	the	_
77-10	10676-10683	context	_
77-11	10684-10686	in	_
77-12	10687-10692	which	_
77-13	10693-10696	the	_
77-14	10697-10703	letter	_
77-15	10704-10705	X	_
77-16	10706-10712	occurs	_
77-17	10713-10716	and	_
77-18	10717-10719	to	_
77-19	10720-10728	maintain	_
77-20	10729-10732	the	_
77-21	10733-10737	task	_
77-22	10738-10742	goal	_
77-23	10743-10753	throughout	_
77-24	10754-10764	processing	_
77-25	10765-10766	.	_

Text=D-prime values were computed as a measure of context processing, using accuracy on AX trials, controlling for errors on BX trials.
78-1	10767-10774	D-prime	_
78-2	10775-10781	values	_
78-3	10782-10786	were	_
78-4	10787-10795	computed	_
78-5	10796-10798	as	_
78-6	10799-10800	a	_
78-7	10801-10808	measure	_
78-8	10809-10811	of	_
78-9	10812-10819	context	_
78-10	10820-10830	processing	_
78-11	10831-10832	,	_
78-12	10833-10838	using	_
78-13	10839-10847	accuracy	_
78-14	10848-10850	on	_
78-15	10851-10853	AX	_
78-16	10854-10860	trials	_
78-17	10861-10862	,	_
78-18	10863-10874	controlling	_
78-19	10875-10878	for	_
78-20	10879-10885	errors	_
78-21	10886-10888	on	_
78-22	10889-10891	BX	_
78-23	10892-10898	trials	_
78-24	10899-10900	.	_

Text=This provides a measure of the ability to maintain context (having just seen an A) in order to correctly respond to the target (X), taking into account false alarms to BX trials (d ’ context = z (AX accuracy) - z (BX error)).
79-1	10901-10905	This	_
79-2	10906-10914	provides	_
79-3	10915-10916	a	_
79-4	10917-10924	measure	_
79-5	10925-10927	of	_
79-6	10928-10931	the	_
79-7	10932-10939	ability	_
79-8	10940-10942	to	_
79-9	10943-10951	maintain	_
79-10	10952-10959	context	_
79-11	10960-10961	(	_
79-12	10962-10968	having	_
79-13	10969-10973	just	_
79-14	10974-10978	seen	_
79-15	10979-10981	an	_
79-16	10982-10983	A	_
79-17	10984-10985	)	_
79-18	10986-10988	in	_
79-19	10989-10994	order	_
79-20	10995-10997	to	_
79-21	10998-11007	correctly	_
79-22	11008-11015	respond	_
79-23	11016-11018	to	_
79-24	11019-11022	the	_
79-25	11023-11029	target	_
79-26	11030-11031	(	_
79-27	11032-11033	X	_
79-28	11034-11035	)	_
79-29	11036-11037	,	_
79-30	11038-11044	taking	_
79-31	11045-11049	into	_
79-32	11050-11057	account	_
79-33	11058-11063	false	_
79-34	11064-11070	alarms	_
79-35	11071-11073	to	_
79-36	11074-11076	BX	_
79-37	11077-11083	trials	_
79-38	11084-11085	(	_
79-39	11086-11087	d	_
79-40	11088-11089	’	_
79-41	11090-11097	context	_
79-42	11098-11099	=	_
79-43	11100-11101	z	_
79-44	11102-11103	(	_
79-45	11104-11106	AX	_
79-46	11107-11115	accuracy	_
79-47	11116-11117	)	_
79-48	11118-11119	-	_
79-49	11120-11121	z	_
79-50	11122-11123	(	_
79-51	11124-11126	BX	_
79-52	11127-11132	error	_
79-53	11133-11134	)	_
79-54	11135-11136	)	_
79-55	11137-11138	.	_

Text=Procedure Stimuli were presented through Beyer dynamic headphones using Presentation software (Neurobehavioral Systems).
80-1	11139-11148	Procedure	_
80-2	11149-11156	Stimuli	_
80-3	11157-11161	were	_
80-4	11162-11171	presented	_
80-5	11172-11179	through	_
80-6	11180-11185	Beyer	_
80-7	11186-11193	dynamic	_
80-8	11194-11204	headphones	_
80-9	11205-11210	using	_
80-10	11211-11223	Presentation	_
80-11	11224-11232	software	_
80-12	11233-11234	(	_
80-13	11235-11250	Neurobehavioral	_
80-14	11251-11258	Systems	_
80-15	11259-11260	)	_
80-16	11261-11262	.	_

Text=Trials began with a white fixation marker at the center of the screen.
81-1	11263-11269	Trials	_
81-2	11270-11275	began	_
81-3	11276-11280	with	_
81-4	11281-11282	a	_
81-5	11283-11288	white	_
81-6	11289-11297	fixation	_
81-7	11298-11304	marker	_
81-8	11305-11307	at	_
81-9	11308-11311	the	_
81-10	11312-11318	center	_
81-11	11319-11321	of	_
81-12	11322-11325	the	_
81-13	11326-11332	screen	_
81-14	11333-11334	.	_

Text=The fixation marker was present from 1000 ms before stimulus onset and remained on the screen throughout presentation of the story.
82-1	11335-11338	The	_
82-2	11339-11347	fixation	_
82-3	11348-11354	marker	_
82-4	11355-11358	was	_
82-5	11359-11366	present	_
82-6	11367-11371	from	_
82-7	11372-11376	1000	_
82-8	11377-11379	ms	_
82-9	11380-11386	before	_
82-10	11387-11395	stimulus	_
82-11	11396-11401	onset	_
82-12	11402-11405	and	_
82-13	11406-11414	remained	_
82-14	11415-11417	on	_
82-15	11418-11421	the	_
82-16	11422-11428	screen	_
82-17	11429-11439	throughout	_
82-18	11440-11452	presentation	_
82-19	11453-11455	of	_
82-20	11456-11459	the	_
82-21	11460-11465	story	_
82-22	11466-11467	.	_

Text=Following story offset, the fixation marker remained on the screen for 1000 ms, and was then replaced by a true/false comprehension question.
83-1	11468-11477	Following	_
83-2	11478-11483	story	_
83-3	11484-11490	offset	_
83-4	11491-11492	,	_
83-5	11493-11496	the	_
83-6	11497-11505	fixation	_
83-7	11506-11512	marker	_
83-8	11513-11521	remained	_
83-9	11522-11524	on	_
83-10	11525-11528	the	_
83-11	11529-11535	screen	_
83-12	11536-11539	for	_
83-13	11540-11544	1000	_
83-14	11545-11547	ms	_
83-15	11548-11549	,	_
83-16	11550-11553	and	_
83-17	11554-11557	was	_
83-18	11558-11562	then	_
83-19	11563-11571	replaced	_
83-20	11572-11574	by	_
83-21	11575-11576	a	_
83-22	11577-11587	true/false	_
83-23	11588-11601	comprehension	_
83-24	11602-11610	question	_
83-25	11611-11612	.	_

Text=Questions never queried information from the fourth sentence, which contained the critical target words.
84-1	11613-11622	Questions	_
84-2	11623-11628	never	_
84-3	11629-11636	queried	_
84-4	11637-11648	information	_
84-5	11649-11653	from	_
84-6	11654-11657	the	_
84-7	11658-11664	fourth	_
84-8	11665-11673	sentence	_
84-9	11674-11675	,	_
84-10	11676-11681	which	_
84-11	11682-11691	contained	_
84-12	11692-11695	the	_
84-13	11696-11704	critical	_
84-14	11705-11711	target	_
84-15	11712-11717	words	_
84-16	11718-11719	.	_

Text=Participants were asked to make a true/false response via button press.
85-1	11720-11732	Participants	_
85-2	11733-11737	were	_
85-3	11738-11743	asked	_
85-4	11744-11746	to	_
85-5	11747-11751	make	_
85-6	11752-11753	a	_
85-7	11754-11764	true/false	_
85-8	11765-11773	response	_
85-9	11774-11777	via	_
85-10	11778-11784	button	_
85-11	11785-11790	press	_
85-12	11791-11792	.	_

Text=Comprehension questions remained on the screen until participants responded.
86-1	11793-11806	Comprehension	_
86-2	11807-11816	questions	_
86-3	11817-11825	remained	_
86-4	11826-11828	on	_
86-5	11829-11832	the	_
86-6	11833-11839	screen	_
86-7	11840-11845	until	_
86-8	11846-11858	participants	_
86-9	11859-11868	responded	_
86-10	11869-11870	.	_

Text=Each stimulus list was divided into 20 blocks for presentation.
87-1	11871-11875	Each	_
87-2	11876-11884	stimulus	_
87-3	11885-11889	list	_
87-4	11890-11893	was	_
87-5	11894-11901	divided	_
87-6	11902-11906	into	_
87-7	11907-11909	20	_
87-8	11910-11916	blocks	_
87-9	11917-11920	for	_
87-10	11921-11933	presentation	_
87-11	11934-11935	.	_

Text=Participants completed the 20 blocks from one list over two EEG sessions.
88-1	11936-11948	Participants	_
88-2	11949-11958	completed	_
88-3	11959-11962	the	_
88-4	11963-11965	20	_
88-5	11966-11972	blocks	_
88-6	11973-11977	from	_
88-7	11978-11981	one	_
88-8	11982-11986	list	_
88-9	11987-11991	over	_
88-10	11992-11995	two	_
88-11	11996-11999	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
88-12	12000-12008	sessions	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
88-13	12009-12010	.	_

Text=Each session began with a practice block consisting of 8 stories.
89-1	12011-12015	Each	_
89-2	12016-12023	session	_
89-3	12024-12029	began	_
89-4	12030-12034	with	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-5	12035-12036	a	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-6	12037-12045	practice	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-7	12046-12051	block	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-8	12052-12062	consisting	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-9	12063-12065	of	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-10	12066-12067	8	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
89-11	12068-12075	stories	_
89-12	12076-12077	.	_

Text=Lists and blocks were presented in counterbalanced order across participants.
90-1	12078-12083	Lists	_
90-2	12084-12087	and	_
90-3	12088-12094	blocks	_
90-4	12095-12099	were	_
90-5	12100-12109	presented	_
90-6	12110-12112	in	_
90-7	12113-12128	counterbalanced	_
90-8	12129-12134	order	_
90-9	12135-12141	across	_
90-10	12142-12154	participants	_
90-11	12155-12156	.	_

Text=Participants completed the behavioral tasks after the second EEG session.
91-1	12157-12169	Participants	_
91-2	12170-12179	completed	_
91-3	12180-12183	the	_
91-4	12184-12194	behavioral	_
91-5	12195-12200	tasks	_
91-6	12201-12206	after	_
91-7	12207-12210	the	_
91-8	12211-12217	second	_
91-9	12218-12221	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
91-10	12222-12229	session	_
91-11	12230-12231	.	_

Text=EEG Recording & Processing EEG was recorded from 29 tin electrodes fitted in an elastic cap (ElectroCap International).
92-1	12232-12235	EEG	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
92-2	12236-12245	Recording	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
92-3	12246-12247	&	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
92-4	12248-12258	Processing	http://maven.renci.org/NeuroBridge/neurobridge#AffectiveProcessingScale
92-5	12259-12262	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
92-6	12263-12266	was	_
92-7	12267-12275	recorded	_
92-8	12276-12280	from	_
92-9	12281-12283	29	_
92-10	12284-12287	tin	_
92-11	12288-12298	electrodes	_
92-12	12299-12305	fitted	_
92-13	12306-12308	in	_
92-14	12309-12311	an	_
92-15	12312-12319	elastic	_
92-16	12320-12323	cap	_
92-17	12324-12325	(	_
92-18	12326-12336	ElectroCap	_
92-19	12337-12350	International	_
92-20	12351-12352	)	_
92-21	12353-12354	.	_

Text=The right mastoid electrode was used as the recording reference for all electrodes except those used to measure eye-movements.
93-1	12355-12358	The	_
93-2	12359-12364	right	_
93-3	12365-12372	mastoid	_
93-4	12373-12382	electrode	_
93-5	12383-12386	was	_
93-6	12387-12391	used	_
93-7	12392-12394	as	_
93-8	12395-12398	the	_
93-9	12399-12408	recording	_
93-10	12409-12418	reference	_
93-11	12419-12422	for	_
93-12	12423-12426	all	_
93-13	12427-12437	electrodes	_
93-14	12438-12444	except	_
93-15	12445-12450	those	_
93-16	12451-12455	used	_
93-17	12456-12458	to	_
93-18	12459-12466	measure	_
93-19	12467-12480	eye-movements	_
93-20	12481-12482	.	_

Text=For these, electrodes above and below the left eye were referenced to each other and used to measure blinks; in addition, two electrodes at the outer canthi of each eye were referenced to each other and used to measure other eye-movements.
94-1	12483-12486	For	_
94-2	12487-12492	these	_
94-3	12493-12494	,	_
94-4	12495-12505	electrodes	_
94-5	12506-12511	above	_
94-6	12512-12515	and	_
94-7	12516-12521	below	_
94-8	12522-12525	the	_
94-9	12526-12530	left	_
94-10	12531-12534	eye	_
94-11	12535-12539	were	_
94-12	12540-12550	referenced	_
94-13	12551-12553	to	_
94-14	12554-12558	each	_
94-15	12559-12564	other	_
94-16	12565-12568	and	_
94-17	12569-12573	used	_
94-18	12574-12576	to	_
94-19	12577-12584	measure	_
94-20	12585-12591	blinks	_
94-21	12592-12593	;	_
94-22	12594-12596	in	_
94-23	12597-12605	addition	_
94-24	12606-12607	,	_
94-25	12608-12611	two	_
94-26	12612-12622	electrodes	_
94-27	12623-12625	at	_
94-28	12626-12629	the	_
94-29	12630-12635	outer	_
94-30	12636-12642	canthi	_
94-31	12643-12645	of	_
94-32	12646-12650	each	_
94-33	12651-12654	eye	_
94-34	12655-12659	were	_
94-35	12660-12670	referenced	_
94-36	12671-12673	to	_
94-37	12674-12678	each	_
94-38	12679-12684	other	_
94-39	12685-12688	and	_
94-40	12689-12693	used	_
94-41	12694-12696	to	_
94-42	12697-12704	measure	_
94-43	12705-12710	other	_
94-44	12711-12724	eye-movements	_
94-45	12725-12726	.	_

Text=Recordings from a left mastoid electrode were also obtained, and used for later re-referencing offline to the algebraic average of both mastoids.
95-1	12727-12737	Recordings	_
95-2	12738-12742	from	_
95-3	12743-12744	a	_
95-4	12745-12749	left	_
95-5	12750-12757	mastoid	_
95-6	12758-12767	electrode	_
95-7	12768-12772	were	_
95-8	12773-12777	also	_
95-9	12778-12786	obtained	_
95-10	12787-12788	,	_
95-11	12789-12792	and	_
95-12	12793-12797	used	_
95-13	12798-12801	for	_
95-14	12802-12807	later	_
95-15	12808-12822	re-referencing	_
95-16	12823-12830	offline	_
95-17	12831-12833	to	_
95-18	12834-12837	the	_
95-19	12838-12847	algebraic	_
95-20	12848-12855	average	_
95-21	12856-12858	of	_
95-22	12859-12863	both	_
95-23	12864-12872	mastoids	_
95-24	12873-12874	.	_

Text=EEG was recorded using a Neuroscan Synamps 2 system, and digitized at a rate of 500 Hz, with half-amplitude cutoffs of .05 to 100 Hz.
96-1	12875-12878	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
96-2	12879-12882	was	_
96-3	12883-12891	recorded	_
96-4	12892-12897	using	_
96-5	12898-12899	a	_
96-6	12900-12909	Neuroscan	_
96-7	12910-12917	Synamps	_
96-8	12918-12919	2	_
96-9	12920-12926	system	_
96-10	12927-12928	,	_
96-11	12929-12932	and	_
96-12	12933-12942	digitized	_
96-13	12943-12945	at	_
96-14	12946-12947	a	_
96-15	12948-12952	rate	_
96-16	12953-12955	of	_
96-17	12956-12959	500	_
96-18	12960-12962	Hz	_
96-19	12963-12964	,	_
96-20	12965-12969	with	_
96-21	12970-12984	half-amplitude	_
96-22	12985-12992	cutoffs	_
96-23	12993-12995	of	_
96-24	12996-12999	.05	_
96-25	13000-13002	to	_
96-26	13003-13006	100	_
96-27	13007-13009	Hz	_
96-28	13010-13011	.	_

Text=Electrode impedances were kept below 5 kΩ.
97-1	13012-13021	Electrode	_
97-2	13022-13032	impedances	_
97-3	13033-13037	were	_
97-4	13038-13042	kept	_
97-5	13043-13048	below	_
97-6	13049-13050	5	_
97-7	13051-13053	kΩ	_
97-8	13054-13055	.	_

Text=MATLAB (Mathworks) was used to process and analyze data, with the EEGlab toolbox and ERPlab plugin, along with custom MATLAB code.
98-1	13056-13062	MATLAB	_
98-2	13063-13064	(	_
98-3	13065-13074	Mathworks	_
98-4	13075-13076	)	_
98-5	13077-13080	was	_
98-6	13081-13085	used	_
98-7	13086-13088	to	_
98-8	13089-13096	process	_
98-9	13097-13100	and	_
98-10	13101-13108	analyze	_
98-11	13109-13113	data	_
98-12	13114-13115	,	_
98-13	13116-13120	with	_
98-14	13121-13124	the	_
98-15	13125-13131	EEGlab	_
98-16	13132-13139	toolbox	_
98-17	13140-13143	and	_
98-18	13144-13150	ERPlab	_
98-19	13151-13157	plugin	_
98-20	13158-13159	,	_
98-21	13160-13165	along	_
98-22	13166-13170	with	_
98-23	13171-13177	custom	_
98-24	13178-13184	MATLAB	_
98-25	13185-13189	code	_
98-26	13190-13191	.	_

Text=Independent component analysis (ICA) was used to correct for artifacts caused by blinks, and single-trial waveforms were additionally screened for horizontal eye-movements, and any remaining blinks or movement-related artifacts.
99-1	13192-13203	Independent	_
99-2	13204-13213	component	_
99-3	13214-13222	analysis	_
99-4	13223-13224	(	_
99-5	13225-13228	ICA	_
99-6	13229-13230	)	_
99-7	13231-13234	was	_
99-8	13235-13239	used	_
99-9	13240-13242	to	_
99-10	13243-13250	correct	_
99-11	13251-13254	for	_
99-12	13255-13264	artifacts	_
99-13	13265-13271	caused	_
99-14	13272-13274	by	_
99-15	13275-13281	blinks	_
99-16	13282-13283	,	_
99-17	13284-13287	and	_
99-18	13288-13300	single-trial	_
99-19	13301-13310	waveforms	_
99-20	13311-13315	were	_
99-21	13316-13328	additionally	_
99-22	13329-13337	screened	_
99-23	13338-13341	for	_
99-24	13342-13352	horizontal	_
99-25	13353-13366	eye-movements	_
99-26	13367-13368	,	_
99-27	13369-13372	and	_
99-28	13373-13376	any	_
99-29	13377-13386	remaining	_
99-30	13387-13393	blinks	_
99-31	13394-13396	or	_
99-32	13397-13413	movement-related	_
99-33	13414-13423	artifacts	_
99-34	13424-13425	.	_

Text=These artifact correction and rejection procedures were performed using epochs of 1200 ms for ERP analysis time-locked to the critical words (−200 to 1000 ms with respect to critical word onset).
100-1	13426-13431	These	_
100-2	13432-13440	artifact	_
100-3	13441-13451	correction	_
100-4	13452-13455	and	_
100-5	13456-13465	rejection	_
100-6	13466-13476	procedures	_
100-7	13477-13481	were	_
100-8	13482-13491	performed	_
100-9	13492-13497	using	_
100-10	13498-13504	epochs	_
100-11	13505-13507	of	_
100-12	13508-13512	1200	_
100-13	13513-13515	ms	_
100-14	13516-13519	for	_
100-15	13520-13523	ERP	_
100-16	13524-13532	analysis	_
100-17	13533-13544	time-locked	_
100-18	13545-13547	to	_
100-19	13548-13551	the	_
100-20	13552-13560	critical	_
100-21	13561-13566	words	_
100-22	13567-13568	(	_
100-23	13569-13573	−200	_
100-24	13574-13576	to	_
100-25	13577-13581	1000	_
100-26	13582-13584	ms	_
100-27	13585-13589	with	_
100-28	13590-13597	respect	_
100-29	13598-13600	to	_
100-30	13601-13609	critical	_
100-31	13610-13614	word	_
100-32	13615-13620	onset	_
100-33	13621-13622	)	_
100-34	13623-13624	.	_

Text=Baseline correction was performed using a −200 to 0 ms window relative to critical word onset.
101-1	13625-13633	Baseline	_
101-2	13634-13644	correction	_
101-3	13645-13648	was	_
101-4	13649-13658	performed	_
101-5	13659-13664	using	_
101-6	13665-13666	a	_
101-7	13667-13671	−200	_
101-8	13672-13674	to	_
101-9	13675-13676	0	_
101-10	13677-13679	ms	_
101-11	13680-13686	window	_
101-12	13687-13695	relative	_
101-13	13696-13698	to	_
101-14	13699-13707	critical	_
101-15	13708-13712	word	_
101-16	13713-13718	onset	_
101-17	13719-13720	.	_

Text=Average ERPs were computed using artifact-free trials in each of the two conditions.
102-1	13721-13728	Average	_
102-2	13729-13733	ERPs	_
102-3	13734-13738	were	_
102-4	13739-13747	computed	_
102-5	13748-13753	using	_
102-6	13754-13767	artifact-free	_
102-7	13768-13774	trials	_
102-8	13775-13777	in	_
102-9	13778-13782	each	_
102-10	13783-13785	of	_
102-11	13786-13789	the	_
102-12	13790-13793	two	_
102-13	13794-13804	conditions	_
102-14	13805-13806	.	_

Text=Four participants in the schizophrenia group and three in the healthy control group were excluded from all analyses because too few artifact-free trials (<20 per condition) remained following artifact correction and rejection procedures.
103-1	13807-13811	Four	_
103-2	13812-13824	participants	_
103-3	13825-13827	in	_
103-4	13828-13831	the	_
103-5	13832-13845	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
103-6	13846-13851	group	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
103-7	13852-13855	and	_
103-8	13856-13861	three	_
103-9	13862-13864	in	_
103-10	13865-13868	the	_
103-11	13869-13876	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
103-12	13877-13884	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
103-13	13885-13890	group	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
103-14	13891-13895	were	_
103-15	13896-13904	excluded	_
103-16	13905-13909	from	_
103-17	13910-13913	all	_
103-18	13914-13922	analyses	_
103-19	13923-13930	because	_
103-20	13931-13934	too	_
103-21	13935-13938	few	_
103-22	13939-13952	artifact-free	_
103-23	13953-13959	trials	_
103-24	13960-13961	(	_
103-25	13962-13963	<	_
103-26	13964-13966	20	_
103-27	13967-13970	per	_
103-28	13971-13980	condition	_
103-29	13981-13982	)	_
103-30	13983-13991	remained	_
103-31	13992-14001	following	_
103-32	14002-14010	artifact	_
103-33	14011-14021	correction	_
103-34	14022-14025	and	_
103-35	14026-14035	rejection	_
103-36	14036-14046	procedures	_
103-37	14047-14048	.	_

Text=The remaining participants in the HC group (N=23) had an average of 33 artifact-free Animate trials (SD: 5.1) and 32 artifact-free Inanimate trials (SD: 5.5).
104-1	14049-14052	The	_
104-2	14053-14062	remaining	_
104-3	14063-14075	participants	_
104-4	14076-14078	in	_
104-5	14079-14082	the	_
104-6	14083-14085	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
104-7	14086-14091	group	_
104-8	14092-14093	(	_
104-9	14094-14098	N=23	_
104-10	14099-14100	)	_
104-11	14101-14104	had	_
104-12	14105-14107	an	_
104-13	14108-14115	average	_
104-14	14116-14118	of	_
104-15	14119-14121	33	_
104-16	14122-14135	artifact-free	_
104-17	14136-14143	Animate	_
104-18	14144-14150	trials	_
104-19	14151-14152	(	_
104-20	14153-14155	SD	_
104-21	14156-14157	:	_
104-22	14158-14161	5.1	_
104-23	14162-14163	)	_
104-24	14164-14167	and	_
104-25	14168-14170	32	_
104-26	14171-14184	artifact-free	_
104-27	14185-14194	Inanimate	_
104-28	14195-14201	trials	_
104-29	14202-14203	(	_
104-30	14204-14206	SD	_
104-31	14207-14208	:	_
104-32	14209-14212	5.5	_
104-33	14213-14214	)	_
104-34	14215-14216	.	_

Text=The remaining participants in the SZ group (N=26) had an average of 31 artifact-free Animate trials (SD: 5.8) and 30 artifact-free Inanimate trials (SD: 5.8).
105-1	14217-14220	The	_
105-2	14221-14230	remaining	_
105-3	14231-14243	participants	_
105-4	14244-14246	in	_
105-5	14247-14250	the	_
105-6	14251-14253	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
105-7	14254-14259	group	_
105-8	14260-14261	(	_
105-9	14262-14266	N=26	_
105-10	14267-14268	)	_
105-11	14269-14272	had	_
105-12	14273-14275	an	_
105-13	14276-14283	average	_
105-14	14284-14286	of	_
105-15	14287-14289	31	_
105-16	14290-14303	artifact-free	_
105-17	14304-14311	Animate	_
105-18	14312-14318	trials	_
105-19	14319-14320	(	_
105-20	14321-14323	SD	_
105-21	14324-14325	:	_
105-22	14326-14329	5.8	_
105-23	14330-14331	)	_
105-24	14332-14335	and	_
105-25	14336-14338	30	_
105-26	14339-14352	artifact-free	_
105-27	14353-14362	Inanimate	_
105-28	14363-14369	trials	_
105-29	14370-14371	(	_
105-30	14372-14374	SD	_
105-31	14375-14376	:	_
105-32	14377-14380	5.8	_
105-33	14381-14382	)	_
105-34	14383-14384	.	_

Text=There were no statistically significant differences between groups in the number of trials included.
106-1	14385-14390	There	_
106-2	14391-14395	were	_
106-3	14396-14398	no	_
106-4	14399-14412	statistically	_
106-5	14413-14424	significant	_
106-6	14425-14436	differences	_
106-7	14437-14444	between	_
106-8	14445-14451	groups	_
106-9	14452-14454	in	_
106-10	14455-14458	the	_
106-11	14459-14465	number	_
106-12	14466-14468	of	_
106-13	14469-14475	trials	_
106-14	14476-14484	included	_
106-15	14485-14486	.	_

Text=All ERPs were filtered off-line using a Gaussian low-pass filter (25 Hz half-amplitude cutoff).
107-1	14487-14490	All	_
107-2	14491-14495	ERPs	_
107-3	14496-14500	were	_
107-4	14501-14509	filtered	_
107-5	14510-14518	off-line	_
107-6	14519-14524	using	_
107-7	14525-14526	a	_
107-8	14527-14535	Gaussian	_
107-9	14536-14544	low-pass	_
107-10	14545-14551	filter	_
107-11	14552-14553	(	_
107-12	14554-14556	25	_
107-13	14557-14559	Hz	_
107-14	14560-14574	half-amplitude	_
107-15	14575-14581	cutoff	_
107-16	14582-14583	)	_
107-17	14584-14585	.	_

Text=Statistical analyses were conducted using the filtered data.
108-1	14586-14597	Statistical	_
108-2	14598-14606	analyses	_
108-3	14607-14611	were	_
108-4	14612-14621	conducted	_
108-5	14622-14627	using	_
108-6	14628-14631	the	_
108-7	14632-14640	filtered	_
108-8	14641-14645	data	_
108-9	14646-14647	.	_

Text=For EEG analysis, epochs of 7300 ms were used (−1800 to 5550 ms with respect to 1st and 2nd sentence onset).
109-1	14648-14651	For	_
109-2	14652-14655	EEG	_
109-3	14656-14664	analysis	_
109-4	14665-14666	,	_
109-5	14667-14673	epochs	_
109-6	14674-14676	of	_
109-7	14677-14681	7300	_
109-8	14682-14684	ms	_
109-9	14685-14689	were	_
109-10	14690-14694	used	_
109-11	14695-14696	(	_
109-12	14697-14702	−1800	_
109-13	14703-14705	to	_
109-14	14706-14710	5550	_
109-15	14711-14713	ms	_
109-16	14714-14718	with	_
109-17	14719-14726	respect	_
109-18	14727-14729	to	_
109-19	14730-14733	1st	_
109-20	14734-14737	and	_
109-21	14738-14741	2nd	_
109-22	14742-14750	sentence	_
109-23	14751-14756	onset	_
109-24	14757-14758	)	_
109-25	14759-14760	.	_

Text=EEG spectral power was calculated using the EEGlab toolbox, by convolving single-trial epochs with seven-cycle complex Morlet wavelets.
110-1	14761-14764	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
110-2	14765-14773	spectral	_
110-3	14774-14779	power	_
110-4	14780-14783	was	_
110-5	14784-14794	calculated	_
110-6	14795-14800	using	_
110-7	14801-14804	the	_
110-8	14805-14811	EEGlab	_
110-9	14812-14819	toolbox	_
110-10	14820-14821	,	_
110-11	14822-14824	by	_
110-12	14825-14835	convolving	_
110-13	14836-14848	single-trial	_
110-14	14849-14855	epochs	_
110-15	14856-14860	with	_
110-16	14861-14872	seven-cycle	_
110-17	14873-14880	complex	_
110-18	14881-14887	Morlet	_
110-19	14888-14896	wavelets	_
110-20	14897-14898	.	_

Text=Power for 52 log-spaced frequencies from 4–30Hz was calculated for all trials and log-transformed.
111-1	14899-14904	Power	_
111-2	14905-14908	for	_
111-3	14909-14911	52	_
111-4	14912-14922	log-spaced	_
111-5	14923-14934	frequencies	_
111-6	14935-14939	from	_
111-7	14940-14946	4–30Hz	_
111-8	14947-14950	was	_
111-9	14951-14961	calculated	_
111-10	14962-14965	for	_
111-11	14966-14969	all	_
111-12	14970-14976	trials	_
111-13	14977-14980	and	_
111-14	14981-14996	log-transformed	_
111-15	14997-14998	.	_

Text=The alpha frequency band was defined as 8–12 Hz.
112-1	14999-15002	The	_
112-2	15003-15008	alpha	_
112-3	15009-15018	frequency	_
112-4	15019-15023	band	_
112-5	15024-15027	was	_
112-6	15028-15035	defined	_
112-7	15036-15038	as	_
112-8	15039-15043	8–12	_
112-9	15044-15046	Hz	_
112-10	15047-15048	.	_

